<SEC-DOCUMENT>0001493152-23-016251.txt : 20230511
<SEC-HEADER>0001493152-23-016251.hdr.sgml : 20230511
<ACCEPTANCE-DATETIME>20230511063029
ACCESSION NUMBER:		0001493152-23-016251
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		21
CONFORMED PERIOD OF REPORT:	20230505
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230511
DATE AS OF CHANGE:		20230511

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NextPlat Corp
		CENTRAL INDEX KEY:			0001058307
		STANDARD INDUSTRIAL CLASSIFICATION:	TELEPHONE COMMUNICATIONS (NO RADIO TELEPHONE) [4813]
		IRS NUMBER:				650783722
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40447
		FILM NUMBER:		23908697

	BUSINESS ADDRESS:	
		STREET 1:		3250 MARY ST
		STREET 2:		SUITE 410
		CITY:			COCONUT GROVE
		STATE:			FL
		ZIP:			33133
		BUSINESS PHONE:		1-305-560-5355

	MAIL ADDRESS:	
		STREET 1:		3250 MARY ST
		STREET 2:		SUITE 410
		CITY:			COCONUT GROVE
		STATE:			FL
		ZIP:			33133

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ORBSAT CORP
		DATE OF NAME CHANGE:	20190819

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Orbital Tracking Corp.
		DATE OF NAME CHANGE:	20150128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Great West Resources, Inc.
		DATE OF NAME CHANGE:	20140514
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:NXPL="http://nextplat.com/20230505">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_03C_NXPL_nextplat.com_20230505 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20230505_20230505 -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityCentralIndexKey_0001058307 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-05-05to2023-05-05" name="dei:EntityCentralIndexKey">0001058307</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-05-05to2023-05-05" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="nxpl-20230505.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-05-05to2023-05-05">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001058307</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-05</xbrli:startDate>
        <xbrli:endDate>2023-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-052023-05-05_custom_CommonStockParValue0.0001Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001058307</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NXPL:CommonStockParValue0.0001Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-05</xbrli:startDate>
        <xbrli:endDate>2023-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-052023-05-05_custom_WarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001058307</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NXPL:WarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-05</xbrli:startDate>
        <xbrli:endDate>2023-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>WASHINGTON,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_905_edei--DocumentType_c20230505__20230505_zHxrXeQWYrF7"><ix:nonNumeric contextRef="From2023-05-05to2023-05-05" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PURSUANT
TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DATE
OF REPORT (DATE OF EARLIEST EVENT REPORTED): <span id="xdx_90E_edei--DocumentPeriodEndDate_c20230505__20230505_ziNyW2cu36wb"><ix:nonNumeric contextRef="From2023-05-05to2023-05-05" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">May 5, 2023</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_908_edei--EntityRegistrantName_c20230505__20230505_ztGo1uI7i5e6"><ix:nonNumeric contextRef="From2023-05-05to2023-05-05" name="dei:EntityRegistrantName">NEXTPLAT
CORP</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant as Specified in its Charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20230505__20230505_zjUAtiJoOrsb"><ix:nonNumeric contextRef="From2023-05-05to2023-05-05" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">nevada</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityFileNumber_c20230505__20230505_zlJXt7zJ1aGk"><ix:nonNumeric contextRef="From2023-05-05to2023-05-05" name="dei:EntityFileNumber">001-40447</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityTaxIdentificationNumber_c20230505__20230505_zKtr0dynR3Nk"><ix:nonNumeric contextRef="From2023-05-05to2023-05-05" name="dei:EntityTaxIdentificationNumber">65-0783722</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or Other Jurisdiction <br />
    of Incorporation or Organization)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission
    <br />
    File No.)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer <br />
    Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityAddressAddressLine1_c20230505__20230505_zITuRHHPcQf7"><ix:nonNumeric contextRef="From2023-05-05to2023-05-05" name="dei:EntityAddressAddressLine1">3250
Mary St.</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressAddressLine2_c20230505__20230505_za2RY3uAr4X7"><ix:nonNumeric contextRef="From2023-05-05to2023-05-05" name="dei:EntityAddressAddressLine2">Suite 410</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityAddressCityOrTown_c20230505__20230505_zbCFrZyDn7lg"><ix:nonNumeric contextRef="From2023-05-05to2023-05-05" name="dei:EntityAddressCityOrTown">Coconut
Grove</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressStateOrProvince_c20230505__20230505_z7YoUZI0ZAZ"><ix:nonNumeric contextRef="From2023-05-05to2023-05-05" name="dei:EntityAddressStateOrProvince">FL</ix:nonNumeric></span> <span id="xdx_902_edei--EntityAddressPostalZipCode_c20230505__20230505_zMae6Itn7cu7"><ix:nonNumeric contextRef="From2023-05-05to2023-05-05" name="dei:EntityAddressPostalZipCode">33133</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices and zip code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--CityAreaCode_c20230505__20230505_zqff6YE4N0ce"><ix:nonNumeric contextRef="From2023-05-05to2023-05-05" name="dei:CityAreaCode">(305)</ix:nonNumeric></span>
<span id="xdx_909_edei--LocalPhoneNumber_c20230505__20230505_zjmGejdpuS0e"><ix:nonNumeric contextRef="From2023-05-05to2023-05-05" name="dei:LocalPhoneNumber">560-5355</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&#8217;s
telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed from last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (<i>see </i>General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--WrittenCommunications_c20230505__20230505_znO0csBwfEzg"><ix:nonNumeric contextRef="From2023-05-05to2023-05-05" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--SolicitingMaterial_c20230505__20230505_zRQPj65LJuPj"><ix:nonNumeric contextRef="From2023-05-05to2023-05-05" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--PreCommencementTenderOffer_c20230505__20230505_zO0ogVR5Rjf8"><ix:nonNumeric contextRef="From2023-05-05to2023-05-05" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--PreCommencementIssuerTenderOffer_c20230505__20230505_zN3ZZ468yq1a"><ix:nonNumeric contextRef="From2023-05-05to2023-05-05" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14(c)).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90E_edei--EntityEmergingGrowthCompany_c20230505__20230505_zhAetV1iXAh1"><ix:nonNumeric contextRef="From2023-05-05to2023-05-05" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol (s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--Security12bTitle_c20230505__20230505__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001Member_zc2emznSCXT2"><ix:nonNumeric contextRef="From2023-05-052023-05-05_custom_CommonStockParValue0.0001Member" name="dei:Security12bTitle">Common
    Stock, par value $0.0001</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--TradingSymbol_c20230505__20230505__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001Member_zISt6zW284wk"><ix:nonNumeric contextRef="From2023-05-052023-05-05_custom_CommonStockParValue0.0001Member" name="dei:TradingSymbol">NXPL</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>The
    <span id="xdx_907_edei--SecurityExchangeName_c20230505__20230505__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001Member_zKZBDTFuLBnh"><ix:nonNumeric contextRef="From2023-05-052023-05-05_custom_CommonStockParValue0.0001Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market, Inc.</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--Security12bTitle_c20230505__20230505__us-gaap--StatementClassOfStockAxis__custom--WarrantsMember_z4x7ufxtUlR8"><ix:nonNumeric contextRef="From2023-05-052023-05-05_custom_WarrantsMember" name="dei:Security12bTitle">Warrants</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--TradingSymbol_c20230505__20230505__us-gaap--StatementClassOfStockAxis__custom--WarrantsMember_zSLi8b1Na0k7"><ix:nonNumeric contextRef="From2023-05-052023-05-05_custom_WarrantsMember" name="dei:TradingSymbol">NXPLW</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>The
    <span id="xdx_907_edei--SecurityExchangeName_c20230505__20230505__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001Member_za7qZrNukb8d"><ix:nonNumeric contextRef="From2023-05-052023-05-05_custom_CommonStockParValue0.0001Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market, Inc.</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01. Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 5, 2023, NextPlat Corp (NASDAQ: NXPL, NXPLW) (the &#8220;Company&#8221; or &#8220;NextPlat&#8221;) entered into a Securities Purchase
Agreement (the &#8220;SPA&#8221;) with Progressive Care Inc. (OTCQB: RXMD) (&#8220;Progressive Care&#8221;), pursuant to which the Company
agreed to purchase 455,000 newly issued units of securities from Progressive Care (the &#8220;Units&#8221;) at a price per Unit of $2.20
for an aggregate purchase price of $1 million (the &#8220;Unit Purchase&#8221;). Each Unit consists of one share of common stock, par
value $0.0001 per share, of Progressive Care (&#8220;Common Stock&#8221;) and one warrant to purchase a share of Common Stock (the &#8220;PIPE
Warrants&#8221;). The PIPE Warrants have a three-year term, and will be immediately exercisable. Each PIPE Warrant is exercisable at
$2.20 per share of Common Stock. On May 9, 2023, NextPlat and Progressive Care closed the transactions contemplated in the SPA. Progressive
Care intends to use the net proceeds from the Unit Purchase for its working capital needs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneous
with the closing, Progressive Care entered into a Debt Conversion Agreement (the &#8220;DCA&#8221;) with NextPlat and the other holders
(the &#8220;Holders&#8221;) of that certain Amended and Restated Secured Convertible Promissory Note, dated as of September 2, 2022,
made by Progressive Care in the original face amount of $2,790,885.63 (the &#8220;Note&#8221;). Pursuant to the DCA, NextPlat and the
other Holders agreed to convert the total $2,887,228.53 of outstanding principal and accrued and unpaid interest to Common Stock at a
conversion price of $2.20 per share (the &#8220;Debt Conversion&#8221;). Of the total 1,312,379 shares of Common Stock issued
upon conversion of the Note pursuant to the DCA, NextPlat received 570,599 shares, Charles M. Fernandez, the Executive Chairman and Chief
Executive Officer of NextPlat, received 228,240 shares, and Rodney Barreto received 228,240 shares. In addition, each of the Holders
also received a warrant to purchase one share of Common Stock for each share of Common Stock they received upon conversion of the Note
(the &#8220;Conversion Warrants&#8221;). The Conversion Warrants have a three-year term, and will be immediately exercisable. Each Conversion
Warrant is exercisable at $2.20 per share of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white">Following
the closing of the Unit Purchase and the Debt Conversion, the Progressive Care preferred stock and common stock owned by NextPlat represents
approximately 38.4% of Progressive Care&#8217;s total outstanding voting securities. NextPlat expect to exercise and/or convert such
portion of its convertible and exercisable Progressive Care securities to increase its equity holdings in Progressive Care to more than
50% of Progressive Care&#8217;s issued and outstanding voting securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the same time, Progressive Care and NextPlat entered into a First Amendment (the &#8220;Amendment&#8221;) to that certain Securities
Purchase Agreement dated November 16, 2022 (the &#8220;Debenture Purchase Agreement&#8221;). Under the Debenture Purchase Agreement,
Progressive Care agreed to issue, and NextPlat Corp agreed to purchase, from time to time during the three-year term of the Debenture
Purchase Agreement, up to an aggregate of $10 million of secured convertible debentures from the Company (the &#8220;Debentures&#8221;).
Pursuant to the Amendment, NextPlat and Progressive Care agreed to amend the Debenture Purchase Agreement and the form of Debenture attached
as an exhibit thereto to have a conversion price of $2.20 per share. At present, no Debentures have been purchased by NextPlat under
the Debenture Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, Progressive Care issued warrants to certain existing Progressive Care investors to induce them to approve the transaction contemplated
by the SPA (the &#8220;Inducement Warrants&#8221;). Charles M. Fernandez and Rodney Barreto received Inducement Warrants to purchase
190,000 and 30,000 shares of Common Stock, respectively. The Inducement Warrants have a three-year term, and will be immediately exercisable.
Each Inducement Warrant is exercisable at $2.20 per share of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing summaries of the SPA, PIPE Warrants, DCA, Conversion Warrants, Amendment, and Inducement Warrants do not purport to be complete
and are subject to, and qualified in their entirety, by reference to the SPA, Form of PIPE Warrant, DCA, Form of Conversion Warrants,
Amendment, and Form of Inducement Warrants attached hereto as Exhibits 10.1, 10.2, 10.3, 10.4, 10.5 and 99.1 respectively, which are
incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
8.01. Other Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white">On
May 10, 2023, NextPlat engaged Dawson James Securities, Inc. to advise the Company in connection with its consideration of a possible
spinoff of its Global Telesat Communications Ltd and Orbital Satcom Corp business units as NextPlat continues its transition to a global
e-commerce and technology company.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 11, 2023, NextPlat issued a press release announcing the Unit Purchase and related transactions, a copy of which is attached
as Exhibit 99.2 to this Current Report on Form 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXHIBIT
INDEX</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.65in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No.</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities Purchase Agreement, dated May 5, 2023, by and between NextPlat and Progressive Care Inc.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of PIPE Warrant</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt Conversion Agreement, dated May 9, 2023, by and between the NextPlat, Progressive Care Inc., Charles Fernandez, Rodney Barreto, Daniyel Erdberg, and Sixth Borough Capital LLC.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Conversion Warrant</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-5.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">First Amendment to Securities Purchase Agreement, dated May 9,2023, by and between NextPlat and Progressive Care Inc. </span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Form of Inducement Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex99-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release dated May 11, 2023.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">SIGNATURE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEXTPLAT
    CORP.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Charles M. Fernandez</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles
    M. Fernandez</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    and Chief Executive Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    May 11, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1j0FOwzAQRU+QO4willFrB4pQdiWCCpGiKlSFrUmmyGriicZOoEfiljgOERuwLHns/998Txwn8YbudYMMr7dlAXtsu0Y5hBKPyGgq9I784TEDf5b4rq1jZVy4zmBOnkHPrBbyRnkhWAdtsc5ArJZSLNNLX2RX17DextGo52SOukbjtGpAmRp2TB1rdIrPU4e9+iRD7TlEHZCtJpOBXIhJ/oJUyBSeaFAfxCcLRZHHURJWFG+Y+m6M6a2jFu4abH2WndDfHb5SBU/2oniczG6xfUP271KkPmL9kzfLf5B+/pbMs6PqtFN8UE2PYiGEkP+0mvwQgAQ6xTCMDFxM1JzwDe6IdbY= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of May 5, 2023, between Progressive Care Inc., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including its successors
and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act (as defined below),
and/or Rule 506 of Regulation D promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser,
severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
1<BR>
<BR>
DEFINITIONS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement: (a) capitalized terms that are not otherwise defined
herein have the meanings given to such terms in the Certificate of Designation (as defined herein), and (b) the following terms have
the meanings set forth in this Section 1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>AFS</U>&rdquo;
means ArentFox Schiff LLP, 1717 K Street, NW, Washington, DC 20006, counsel to Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of Securities pursuant to Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) each Purchaser&rsquo;s obligations to pay the Closing Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities purchased at such Closing, in each case, have been satisfied or waived, but in no event later than
the third Trading Day following the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Statement</U>&rdquo; means the Closing Statement in the form on <U>Annex A</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Counsel</U>&rdquo; means Lucosky Brookman LLP, 101 Wood Avenue South, Woodbridge, New Jersey 08830.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Convertible
Debt</U>&rdquo; shall mean the accrued and unpaid interest and principal payable under that certain Amended and Restated Secured Convertible
Promissory Note, dated effective as of September 2, 2022, made by the Company for the benefit of the individuals listed on the signature
pages thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Debt
Conversion Agreement</U>&rdquo; means the Debt Conversion Agreement, dated as of the Closing Date, by and between the Company, and the
holders listed on the signature pages thereto pursuant to which the holders agreed to convert all of their portions of the Convertible
Debt at $2.20 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Debt
Conversion Warrants</U>&rdquo; means the Common Stock Purchase Warrants issued to holders under the Debt Conversion Agreement as an inducement
for them to enter into the Debt Conversion Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Schedules</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effective
Date</U>&rdquo; means the earliest of the date that (a) the Registration Statement has been declared effective by the Commission, (b)
all of the Shares and Warrant Shares have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without the requirement
for the Company to be in compliance with the current public information required under Rule 144 and without volume or manner-of-sale
restrictions, (c) following the one year anniversary of the applicable Closing Date provided that a holder of the Shares or Warrant Shares
is not an Affiliate of the Company or (d) all of the Shares or Warrant Shares may be sold pursuant to an exemption from registration
under Section 4(a)(1) of the Securities Act without volume or manner-of-sale restrictions and Company Counsel has delivered to such holders
a standing written unqualified opinion that resales may then be made by such holders of the Shares or Warrant Shares pursuant to such
exemption which opinion shall be in form and substance reasonably acceptable to such holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company pursuant
to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority
of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) securities
upon the exercise or exchange of or conversion of any Securities issued hereunder, and/or other securities exercisable or exchangeable
for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have
not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange
price or conversion price of such securities (other than in connection with stock splits or combinations) or to extend the term of such
securities, and (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the members of the
Board of Directors of the Company, including a majority of the disinterested directors of the Company, provided that such securities
are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights that require or permit the
filing of any registration statement in connection therewith during the prohibition period in Section 4.13(a) herein, and provided that
any such issuance shall only be to a Person (or to the equity holders of a Person) which is, itself or through its subsidiaries, an operating
company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company additional
benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily
for the purpose of raising capital or to an entity whose primary business is investing in securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FDA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(jj).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Governmental
Authority</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(tt).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Health
Care Laws</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(tt).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(bb).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Legend
Removal Date</U>&rdquo; shall have the meaning ascribed to such term in Section 4.1(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(m).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Participation
Maximum</U>&rdquo; shall have the meaning ascribed to such term in Section 4.12(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Per
Unit Purchase Price</U>&rdquo; means $2.20 per Unit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pharmaceutical
Product</U>&rdquo; means each product subject to the jurisdiction of the FDA under the Federal Food, Drug and Cosmetic Act, as amended,
or similar regulatory authorities outside the United States and the regulations thereunder that is manufactured, packaged, labeled, tested,
distributed, sold, and/or marketed by the Company or any of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agent</U>&rdquo; means Dawson James Securities, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pledged
Securities</U>&rdquo; means any and all certificates and other instruments representing or evidencing all of the capital stock and other
equity interests of the Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Notice</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.12(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pro
Rata Portion</U>&rdquo; shall have the meaning ascribed to such term in Section 4.12(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Public
Information Failure</U>&rdquo; shall have the meaning ascribed to such term in Section 4.3(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Public
Information Failure Payments</U>&rdquo; shall have the meaning ascribed to such term in Section 4.3(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.10.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Rights Agreement</U>&rdquo; means the Registration Rights Agreement, dated on or about the date hereof, among the Company and the Purchasers,
in the form of <U>Exhibit B</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering
the resale of the Shares, Warrant Shares, and the shares of Common Stock underlying the Debt Conversion Warrants by the Purchasers as
provided for in the Registration Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Reverse
Split</U>&rdquo; shall have the meaning ascribed to such term in Section 4.11(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to
time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Units, Warrants, and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement, but excluding the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for the Shares and Warrants purchased hereunder as specified
below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo;
in United States dollars and in immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on <U>Schedule 3.1(a)</U>, and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York
Stock Exchange, OTCQB or OTCQX as applicable; if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices
for the Common Stock are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting
prices).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Warrants, the Debt Conversion Agreement, the Debt Conversion Warrants, the Registration
Rights Agreement, and all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with
the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means the transfer agent of the Company, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Unit</U>&rdquo;
means one share of Common Stock and one Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in Section 4.13(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a
Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York
City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the
Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed
or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)
in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith
by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and
expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a)
hereof, which warrants shall be exercisable immediately and have a term equal to three (3) years, in the form of <U>Exhibit A</U> attached
hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
2</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURCHASE
AND SALE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Closing</U>. Substantially concurrent with the execution and delivery of this Agreement by the parties hereto, subject to the conditions
set forth herein, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, an aggregate of 455,000
Units at an aggregate Purchase Price of $1,000,000.00 at closing (the &ldquo;<U>Closing</U>&rdquo;). At Closing, each Purchaser shall
deliver to the Company, via wire transfer or a certified check, immediately available funds equal to such Purchaser&rsquo;s Subscription
Amount as set forth on the signature page hereto executed by such Purchaser, the Company shall deliver to each Purchaser its respective
Units, as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section
2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall
occur at the offices of AFS or such other location as the parties shall mutually agree.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
a legal opinion of Company Counsel, directed to the Placement Agent and the Purchasers, in a form reasonably acceptable to the Placement
Agent and the Purchasers;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver on an expedited basis a certificate
evidencing a number of Shares equal to such Purchaser&rsquo;s Subscription Amount divided by the Per Unit Purchase Price, registered
in the name of such Purchaser, or, at the election of such Purchaser, evidence of the issuance of such Purchaser&rsquo;s Shares hereunder
as held in DRS book-entry form by the Transfer Agent and registered in the name of such Purchaser, which evidence shall be reasonably
satisfactory to such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
a Warrant registered in the name of such Purchaser to purchase up to a number of Warrant Shares equal to such Purchaser&rsquo;s Subscription
Amount divided by the Per Unit Purchase Price, with an exercise price equal to $2.20 per Warrant Share, subject to adjustment therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
the Company shall have provided Purchaser with the Company&rsquo;s wire instructions, on Company letterhead and executed by the Chief
Executive Officer or Chief Financial Officer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
the Debt Conversion Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
the Registration Rights Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
a duly executed Officer&rsquo;s Certificate, substantially in the form acceptable to the Purchasers; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
a duly executed Secretary&rsquo;s Certificate, substantially in the form acceptable to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
such Purchaser&rsquo;s Subscription Amount as set forth on such Purchaser&rsquo;s signature page hereto by wire transfer to the account
specified in writing by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the Debt Conversion Agreement duly executed by such Purchaser; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
the Registration Rights Agreement duly executed by such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<U>Closing Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) on the applicable Closing Date of the representations and warranties of the Purchasers contained herein (unless
as of a specific date therein in which case they shall be accurate as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the applicable Closing Date shall
have been performed; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the applicable Closing Date of the representations and warranties of the Company contained
herein (unless as of a specific date therein in which case they shall be accurate as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the applicable Closing Date shall have
been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
from the date hereof to each Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended
or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or on any Trading
Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall there have
occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect
on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of Purchaser, makes it impracticable
or inadvisable to purchase the Securities at the applicable Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
3</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPRESENTATIONS
AND WARRANTIES</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Representations and Warranties of the Company</U>. Except as set forth in the Company&rsquo;s disclosure schedules attached to this
Agreement (the &ldquo;<U>Disclosure Schedules</U>&rdquo;), which Disclosure Schedules shall be deemed a part hereof and shall qualify
any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section of the Disclosure
Schedules, the Company hereby makes the following representations and warranties to Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Subsidiaries</U>. All of the direct and indirect subsidiaries of the Company are set forth on <U>Schedule 3.1(a)</U>. The Company
shall owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens,
and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable
and free of preemptive and similar rights to subscribe for or purchase securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Organization and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned
by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could
not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise)
of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in
any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material
Adverse Effect</U>&rdquo;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking
to revoke, limit or curtail such power and authority or qualification; <U>provided</U>, <U>however</U>, that &ldquo;Material Adverse
Effect&rdquo; shall not include any event, occurrence, fact, condition or change, directly or indirectly, arising out of or attributable
to: (i) general economic or political conditions, (ii) conditions generally affecting the industry in which the Company or any Subsidiary
operates, (iii) any changes in financial or securities markets in general, (iv) acts of war (whether or not declared), armed hostilities
or terrorism, or the escalation or worsening thereof, (v) any pandemic, epidemics or human health crises (including COVID-19), (vi) any
changes in applicable laws or accounting rules (including GAAP), (vii) the announcement, pendency or completion of the transactions contemplated
by the Transaction Documents, or (viii) any action required or permitted by the Transaction Documents or any action taken (or omitted
to be taken) with the written consent of or at the written request of Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no
further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith
other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been
(or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will
constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as
limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby
do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles
of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or
assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings
required pursuant to Section 4.6 of this Agreement, (ii) the filing with the Commission pursuant to the Registration Rights Agreement,
(iii) the notice and/or application(s) to each applicable Trading Market for the issuance and sale of the Securities and the listing
of the Conversion Shares for trading thereon, (iv) the filing of Form D with the Commission and such filings as are required to be made
under applicable state securities laws and (v) Shareholder Approval (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Issuance of the Securities</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company
other than restrictions on transfer provided for in the Transaction Documents. The Warrant Shares, when issued in accordance with the
terms of the Transaction Documents, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the
Company other than restrictions on transfer provided for in the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Capitalization</U>. The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule
3.1(g)</U> shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as
of the date hereof. Except as set forth on Schedule 3.1(g), the Company has not issued any capital stock since its most recently filed
periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&rsquo;s stock
option plans, the issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant
to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under
the Exchange Act. No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate
in the transactions contemplated by the Transaction Documents. Except as set forth on Schedule 3.1(g), as a result of the purchase and
sale of the Securities, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person
any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments,
understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock
or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company
or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Purchasers). Except as set forth
on Schedule 3.1(g), there are no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts
the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities by the Company or any
Subsidiary. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or similar
provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may
become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or &ldquo;phantom
stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are
duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws,
and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities.
No further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the
Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s capital
stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Financial Statements</U>. The financial statements of the Company provided to the Purchasers comply in all material respects with
applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing.
Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent
basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial statements or the
notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all
material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results
of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end
audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Except as set forth on <U>Schedule 3.1(i)</U>, since the date
of the latest audited financial statements, (i) there has been no event, occurrence or development that has had or that could reasonably
be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other
than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities
not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings made with the Commission,
(iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of
cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital
stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company
stock option plans. The Company does not have pending before the Commission any request for confidential treatment of information. Except
for the issuance of the Securities contemplated by this Agreement or as set forth on <U>Schedule 3.1(i)</U>, no event, liability, fact,
circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company
or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition, that would be required
to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been
publicly disclosed at least one (1) Trading Day prior to the date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Litigation</U>. Except as set forth on <U>Schedule 3.1(j)</U>, to the knowledge of the Company, there is no action, suit, inquiry,
notice of violation, proceeding or investigation pending or threatened against or affecting the Company, any Subsidiary or any of their
respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state,
county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth on <U>Schedule 3.1(j)</U>, (i)
adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii)
could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company
nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or
liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of
the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former
director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration
statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe
that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary,
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local
and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that
has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor
has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator
or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental
authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational
health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be
expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Environmental Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating
to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface
strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or
toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating
to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well
as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders,
permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have
received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses;
and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and
(iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations, licenses and permits issued by
the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses, except where
the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material Permits</U>&rdquo;),
and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material
Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them
and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of
which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Intellectual Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights necessary or required for use in connection with their respective businesses and which the failure to so have could
have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither the Company
nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated
or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement. Neither
the Company nor any Subsidiary has received, since the date of the latest audited financial statements, a written notice of a claim or
otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could
not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property
Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company
and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual
properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the Company
nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase
in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Transactions with Affiliates and Employees</U>. Except as set forth on <U>Schedule 3.1(r)</U>, none of the officers or directors of
the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently
a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including
any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal
property to or from providing for the borrowing of money from or lending of money to, or otherwise requiring payments to or from any
officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee
has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other
than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company
and (iii) other employee benefits, including stock option agreements under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements
of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated
by the Commission thereunder that are effective as of the date hereof and as of each Closing Date. The Company and the Subsidiaries maintain
a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with
management&rsquo;s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets
at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and
designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it
files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s
rules and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of
the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act
(such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange
Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations
as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as
such term is defined in the Exchange Act) that have materially affected, or is reasonably likely to materially affect, the internal control
over financial reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Transaction Fees</U>. Except for compensation payable to the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are
or will be payable by the Company or any Subsidiaries to any broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no
obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated
in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Private Placement</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, no
registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated
hereby. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities,
will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Registration Rights</U>. Other than each of the Purchasers, no Person has any right to cause the Company or any Subsidiary to effect
the registration under the Securities Act of any securities of the Company or any Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the
laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company
fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of
the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or
counsel with any information that it believes constitutes or might constitute material, non-public information. The Company understands
and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company. All
of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective
businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct and does
not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made
therein, in the light of the circumstances under which they were made, not misleading. The press releases disseminated by the Company
during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of
the circumstances under which they were made and when made, not misleading. The Company acknowledges and agrees that no Purchaser makes
or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set
forth in Section 3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of any
such securities under the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of
the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>Solvency</U>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt
by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known
contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its
business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)
the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature
(taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any
facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from the applicable Closing Date. <U>Schedule 3.1(aa)</U> sets forth as of the date hereof all
outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments.
For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed money or amounts owed in
excess of $100,000 (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements
and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s
consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection
or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $100,000 due
under leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to
any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Tax Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income
and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii)
has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such
returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material
taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material
amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no
basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
<U>No General Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities
by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and
certain other &ldquo;accredited investors&rdquo; within the meaning of Rule 501 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
<U>Foreign Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any
agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law or (iv) violated in any material respect any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
<U>Accountants</U>. The Company&rsquo;s accounting firm is set forth on <U>Schedule 3.1(ee)</U> of the Disclosure Schedules. To the knowledge
and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall
express its opinion with respect to the financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year
ending December 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>No Disagreements with Accountants and Lawyers</U>. There are no disagreements of any kind presently existing, or reasonably anticipated
by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company
is current with respect to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any
of its obligations under any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>Acknowledgment Regarding the Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each Purchaser
is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or
any of its representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely
incidental to such Purchaser&rsquo;s purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Acknowledgment Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Section 4.15 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked by
the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company,
or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified term, (ii)
past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &ldquo;derivative&rdquo;
transactions, before or after the closing of this or future private placement transactions, may negatively impact the market price of
the Company&rsquo;s publicly-traded securities, (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to
which any such Purchaser is a party, directly or indirectly, may presently have a &ldquo;short&rdquo; position in the Common Stock and
(iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo;
transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various
times during the period that the Securities are outstanding, including, without limitation, during the periods that the value of the
Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing stockholders&rsquo;
equity interests in the Company at and after the time that the hedging activities are being conducted. The Company acknowledges that
such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
<U>Regulation M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement
of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>FDA</U>. There is no pending, completed or, to the Company&rsquo;s knowledge, threatened, action (including any lawsuit, arbitration,
or legal or administrative or regulatory proceeding, charge, complaint, or investigation) against the Company or any of its Subsidiaries,
and none of the Company or any of its Subsidiaries has received any notice, warning letter or other communication from the U.S. Food
and Drug Administration (&ldquo;<U>FDA</U>&rdquo;) or any other governmental entity, which (i) contests the premarket clearance, licensure,
registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the
labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of,
or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii) imposes
a clinical hold on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the
Company or any of its Subsidiaries, (v) enters or proposes to enter into a consent decree of permanent injunction with the Company or
any of its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company or any of its Subsidiaries,
and which, either individually or in the aggregate, would have a Material Adverse Effect. The properties, business and operations of
the Company have been and are being conducted in all material respects in accordance with all applicable laws, rules and regulations
of the FDA and state and local authorities. The Company has not been informed by the FDA (or any state or local authority) that the FDA
(or any state or local authority) will prohibit the marketing, sale, license or use in the United States of any product proposed to be
developed, produced or marketed, or currently being produced and marketed, by the Company nor has the FDA (or any state or local authority)
expressed any concern as to approving or clearing for marketing any product being developed or proposed to be developed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>Non-Debarment and Non-Disqualification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Neither the Company, nor any of its Subsidiaries nor any of their respective agents or employees has been, and is not currently an individual
who has been debarred by the FDA pursuant to 21 U.S.C. &sect; 335a (a) or (b) (&ldquo;<U>Debarred Individual</U>&rdquo;) from providing
services in any capacity to a person that has an approved or pending drug product application, or an employer, employee or partner of
a Debarred Individual, or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Neither the Company, nor any of its Subsidiaries nor any of their respective agents or employees has been, and is not currently a corporation,
partnership or association that has been debarred by the FDA pursuant to 21 U.S.C. &sect; 335a (a) or (b) (&ldquo;<U>Debarred Entity</U>&rdquo;)
from submitting or assisting in the submission of any drug application, or an employee, partner, shareholder, member, subsidiary or affiliate
of a Debarred Entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Neither Company, nor its Subsidiaries, nor any of their respective agents or employees has ever been and is not currently the subject
of a sanction or disciplinary action by any federal, state or local agency, including state licensing authorities or regulatory authorities,
medical societies, or specialty boards, or of an agreement with any such agency that restricts their ability to practice medicine (&ldquo;<U>Disciplined
Individual</U>&rdquo;); disqualified by FDA as a clinical investigator pursuant to 21 C.F.R. &sect; 312.70 or 21 C.F.R. &sect; 812.119
(&ldquo;<U>Disqualified Individual</U>&rdquo;); or excluded from participation in federal health care programs (&ldquo;<U>Excluded Individual</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
No Debarred, Disqualified, Disciplined, or Excluded Individual or Debarred Entity has performed or rendered, or will perform or render,
any services or assistance relating to activities of the Company. Company has no knowledge of any circumstances which may affect the
accuracy of the foregoing warranties and representations, including but not limited to, FDA investigations of, or debarment proceedings
against Company, its agents or employees, or any person or entity performing services or rendering assistance relating to Company&rsquo;s
activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>Health Care</U>. Neither the Company and nor any of its Subsidiaries, in the past three (3) years, (i) has received written notice
from any Governmental Authority alleging any material violation (whenever alleged to have occurred) of any applicable Health Care Law
relating to the Company or any of its Subsidiaries that has not been cured; (ii) has received written notice of any legal, administrative,
arbitral or other claim, proceeding, suit, action or investigation alleging any material failure to comply with Health Care Laws by or
from any Governmental Authority that is currently pending and, to the Company&rsquo;s and each of its Subsidiaries&rsquo; knowledge,
no such claim, proceeding, suit, action or investigation alleging any material failure to comply with Health Care Laws has been threatened
in writing against or affecting the Company or any of its Subsidiaries; and (iii) is in compliance in all material respects with all
applicable Health Care Laws. &ldquo;<U>Governmental Authority</U>&rdquo; means any government, governmental agency, department, bureau,
office, commission, board, authority, or instrumentality, or court of competent jurisdiction, in each case whether foreign, federal,
state, or local. &ldquo;<U>Health Care Laws</U>&rdquo; means (i) any and all laws relating to health care or insurance fraud and abuse,
including, as applicable, the federal Anti-Kickback Statute (42 U.S.C. &sect; 1320a-7b(b) and 41 U.S.C. &sect;&sect; 51-58), the civil
False Claims Act (31 U.S.C. &sect; 3729 et seq.), the Exclusion Laws (42 U.S.C. &sect;&sect; 1320a-7 and 1320a-7a), the Civil Monetary
Penalties Law (42 U.S.C. &sect;&sect; 1320a and 1320a-7b, and the regulations promulgated pursuant to such statutes; (ii) any and all
federal, state and local laws concerning privacy and data security for patient information, including the Health Insurance Portability
and Accountability Act of 1996 (42 U.S.C. &sect;&sect; 1320d-1329d-8), as amended, and all federal and state laws concerning medical
record retention, privacy, security, patient confidentiality and informed consent, and the regulations promulgated thereunder; (iii)
Medicare (Title XVIII of the Social Security Act), as amended and the regulations promulgated thereunder; (iv) Medicaid (Title XIX of
the Social Security Act) and the regulations promulgated thereunder; (v) the Medicare Prescription Drug, Improvement, and Modernization
Act of 2003 (Pub. L. No. 108-173) and the regulations promulgated thereunder; (vi) the Patient Protection and Affordable Care Act (Pub.
L. 111-148), as amended and the regulations promulgated thereunder; (vii) quality, safety and accreditation standards and requirements
of all applicable state laws or regulatory bodies; and (viii) federal and state laws with respect to financial relationships between
referral sources and referral recipients, including, but not limited to the federal Stark Law (42 U.S.C. &sect; 1395nn et seq.) and the
regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
<U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance
with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the
Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the
Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company
policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the
release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or
prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity
of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr)
<U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ss)
<U>No Disqualification Events</U>. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the
Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of
the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity
securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act)
connected with the Company in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo; and, together, &ldquo;<U>Issuer
Covered Persons</U>&rdquo;) is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii)
under the Securities Act (a &ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2)
or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification
Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the
Purchasers a copy of any disclosures provided thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(tt)
<U>Other Covered Persons</U>. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person)
that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(uu)
<U>Notice of Disqualification Events</U>. The Company will notify the Purchasers and the Placement Agent in writing, prior to the Closing
Date of (i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time,
become a Disqualification Event relating to any Issuer Covered Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Representations and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and
warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case
they shall be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and
in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to
which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof,
will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Filings, Consents and Approvals</U>. Such Purchaser is not required to obtain any consent, waiver, authorization or order of, give
any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by such Purchaser of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Own Account</U>. Such Purchaser understands that the Securities are &ldquo;restricted securities&rdquo; and have not been registered
under the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account and
not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable
state securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable
state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the
distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty
not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with
applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Purchaser Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each
date on which it converts any Warrants into Common Stock it will be either: (i) an &ldquo;accredited investor&rdquo; as defined in Rule
501(a)(1), (a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act or (ii) a &ldquo;qualified institutional
buyer&rdquo; as defined in Rule 144A(a) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of
an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>General Solicitation</U>. Such Purchaser is not, to such Purchaser&rsquo;s knowledge, purchasing the Securities as a result of any
advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media
or broadcast over television or radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation
or general advertisement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and has been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and
to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities and the
merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results of
operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity
to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither the Placement
Agent nor any of its Affiliates have provided such Purchaser with any information or advice with respect to the Securities nor is such
information or advice necessary or desired. Neither the Placement Agent nor any of its Affiliates have made or makes any representation
as to the Company or the quality of the Securities and the Placement Agent and any Affiliate of the Placement Agent may have acquired
non-public information with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance
of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary
to such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Litigation</U>. There is no Action pending or threatened against such Purchaser or affecting such Purchaser that adversely affects
or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Office of Foreign Assets Control</U>. Neither such Purchaser nor any of its Subsidiaries nor, to such Purchaser&rsquo;s knowledge,
any director, officer, agent, employee or affiliate of such Purchaser or any its Subsidiaries is currently subject to any U.S. sanctions
administered by OFAC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
4</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
AGREEMENTS OF THE PARTIES</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Transfer Restrictions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities
other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of Purchaser or in connection
with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion
of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the
Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and
the Registration Rights Agreement and shall have the rights and obligations of Purchaser under this Agreement and the Registration Rights
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in the following
form:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[NEITHER]
THIS SECURITY [NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE] HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY [AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY] MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL
INSTITUTION THAT IS AN &ldquo;ACCREDITED INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY
SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered
broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo;
as defined in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer
pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company
and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no
notice shall be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable
documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities,
including, if the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation and filing of
any required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act
to appropriately amend the list of Selling Stockholders (as defined in the Registration Rights Agreement) thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Certificates evidencing the Shares and Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b)
hereof): (i) while a registration statement (including the Registration Statement) covering the resale of such security is effective
under the Securities Act, (ii) following any sale of such Shares or Warrant Shares pursuant to Rule 144 (assuming cashless exercise of
the Warrants), (iii) if such Shares or Warrant Shares are eligible for sale under Rule 144 (assuming cashless exercise of the Warrants),
without the requirement for the Company to be in compliance with the current public information required under Rule 144 as to such Shares
and Warrant Shares and without volume or manner-of-sale restrictions or (iv) if such legend is not required under applicable requirements
of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission). The Company shall
cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser promptly after the Effective Date if required by the
Transfer Agent to effect the removal of the legend hereunder, or if requested by Purchaser, respectively. If all or any portion of a
Warrant is exercised at a time when there is an effective registration statement to cover the resale of the Warrant Shares, or if such
Shares Warrant Shares may be sold under Rule 144 without the requirement for the Company to be in compliance with the current public
information required under Rule 144 as to such Shares or Warrant Shares and without volume or manner-of-sale restrictions or if such
legend is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements
issued by the staff of the Commission) then such Shares or Warrant Shares shall be issued free of all legends. The Company agrees that
following the Effective Date or at such time as such legend is no longer required under this Section 4.1(c), it will, no later than the
earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below)
following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing Warrant Shares, as applicable,
issued with a restrictive legend (such date, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be delivered to such
Purchaser a certificate representing such shares that is free from all restrictive and other legends. The Company may not make any notation
on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4. Warrant
Shares subject to legend removal hereunder shall be transmitted by the Transfer Agent to such Purchaser by crediting the account of such
Purchaser&rsquo;s prime broker with the Depository Trust Company System as directed by such Purchaser. As used herein, &ldquo;<U>Standard
Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
Trading Market with respect to the Common Stock as in effect on the date of delivery of a certificate representing Warrant Shares, as
applicable, issued with a restrictive legend.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
In addition to such Purchaser&rsquo;s other available remedies the Company shall pay to a Purchaser, in cash, (i) as partial liquidated
damages and not as a penalty, for each $1,000 of Warrant Shares (based on the VWAP of the Common Stock on the date such Securities are
submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $5 per Trading Day (increasing
to $10 per Trading Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the Legend Removal Date
until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause to be delivered)
to such Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company by such Purchaser
that is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser purchases (in an open market
transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion of the
number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of shares
of Common Stock that such Purchaser anticipated receiving from the Company without any restrictive legend, then, an amount equal to the
excess of such Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for
the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<B><U>Buy-In
Price</U></B>&rdquo;) over the product of (A) such number of Warrant Shares that the Company was required to deliver to such Purchaser
by the Legend Removal Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing
on the date of the delivery by Purchaser to the Company of the applicable Warrant Shares (as the case may be) and ending on the date
of such delivery and payment under this clause (ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Each Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities
pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or
an exemption therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the
plan of distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities
as set forth in this Section 4.1 is predicated upon the Company&rsquo;s reliance upon this understanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Acknowledgment of Dilution</U>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding
shares of Common Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its
obligations under the Transaction Documents, including, without limitation, its obligation to issue the Warrant Shares pursuant to the
Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless
of the effect of any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive effect that
such issuance may have on the ownership of the other stockholders of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Furnishing of Information; Public Information</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Until the earlier of the time that (i) no Purchaser owns Securities, or (ii) the Warrants have expired, the Company covenants to maintain
the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions in respect
thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to
the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
At any time during the period commencing immediately and ending at such time that all of the Securities may be sold without the requirement
for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, if the
Company (i) shall fail for any reason to satisfy the current public information requirement under Rule 144(c) or (ii) has ever been an
issuer described in Rule 144 (i)(1)(i) or becomes an issuer in the future, and the Company shall fail to satisfy any condition set forth
in Rule 144(i)(2) (a &ldquo;<U>Public Information Failure</U>&rdquo;) then, in addition to a Purchaser&rsquo;s other available remedies,
the Company shall pay to such Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason of any such delay in
or reduction of its ability to sell the Securities, an amount in cash equal to two percent (2.0%) of the Subscription Amount of such
Purchaser&rsquo;s Securities on the day of a Public Information Failure and on every thirtieth (30<SUP>th</SUP>) day (prorated for periods
totaling less than thirty days) thereafter until the earlier of (a) the date such Public Information Failure is cured and (b) such time
that such public information is no longer required for such Purchaser to transfer the Warrant Shares pursuant to Rule 144. The payments
to which a Purchaser shall be entitled pursuant to this Section 4.3(b) are referred to herein as &ldquo;<U>Public Information Failure
Payments</U>.&rdquo; Public Information Failure Payments shall be paid on the earlier of (i) the last day of the calendar month during
which such Public Information Failure Payments are incurred and (ii) the third (3<SUP>rd</SUP>) Business Day after the event or failure
giving rise to the Public Information Failure Payments is cured. In the event the Company fails to make Public Information Failure Payments
in a timely manner, such Public Information Failure Payments shall bear interest at the rate of 1.5% per month (prorated for partial
months) until paid in full. Nothing herein shall limit a Purchaser&rsquo;s right to pursue actual damages for the Public Information
Failure, and each Purchaser shall have the right to pursue all remedies available to it at law or in equity including, without limitation,
a decree of specific performance and/or injunctive relief.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security
(as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would
require the registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of
the Securities for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior
to the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
Reserved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Securities Laws Disclosure; Publicity</U>. As of a date three (3) business days following the Closing, the Company represents to the
Purchasers that it shall have publicly disclosed all material, non-public information delivered to the Purchasers by the Company or any
of its Subsidiaries, or any of their respective officers, directors, employees or agents in connection with the transactions contemplated
by the Transaction Documents. In addition, effective upon the issuance of such press release, the Company acknowledges and agrees that
any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries
or any of their respective officers, directors, agents, employees or Affiliates on the one hand, and a Purchaser or any of its Affiliates
on the other hand, shall terminate. The Company and each Purchaser shall consult with each other in issuing any other press releases
with respect to the transactions contemplated hereby, and neither the Company nor any such Purchaser shall issue any such press release
nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser,
or without the prior consent of such Purchaser, with respect to any press release of the Company, which consent shall not unreasonably
be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other
party with prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall not publicly disclose
the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or Trading
Market, without the prior written consent of such Purchaser, except (a) as required by federal securities law in connection with (i)
any registration statement contemplated by the Registration Rights Agreement and (ii) the filing of final Transaction Documents with
the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall
provide Purchaser with prior notice of such disclosure permitted under this clause (b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Shareholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person,
that any Purchaser is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill
(including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by
the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving
Securities under the Transaction Documents or under any other agreement between the Company and Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Non-Public Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, which shall be disclosed pursuant to Section 4.6, the Company covenants and agrees that neither it, nor any other Person acting
on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information
and agreed with the Company to keep such information confidential. The Company understands and confirms that such Purchaser shall be
relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company, any of its
Subsidiaries, or any of their respective officers, director, agents, employees or Affiliates delivers any material, non-public information
to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall not have any
duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or
Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates
not to trade on the basis of, such material, non-public information, provided that such Purchaser shall remain subject to applicable
law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information
regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current
Report on Form 8-K. The Company understands and confirms that such Purchaser shall be relying on the foregoing covenant in effecting
transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
<U>Use of Proceeds</U>. Except as set forth on <U>Schedule 4.9</U> attached hereto, the Company shall use the net proceeds from the sale
of the Securities hereunder for working capital purposes and shall not use such proceeds: (a) for the satisfaction of any portion of
the Company&rsquo;s debt (other than payment of trade payables in the ordinary course of the Company&rsquo;s business and prior practices),
(b) for the redemption of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in
violation of FCPA or OFAC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
<U>Indemnification of the Purchasers</U>. Subject to the provisions of this Section 4.10, the Company will indemnify and hold each Purchaser
and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser
(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;Purchaser Party&rdquo;) harmless from any and all
losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements,
court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result
of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement
or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their
respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the
transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party&rsquo;s
representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may
have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser
Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct). For the avoidance of doubt,
the Company will reimburse each Purchaser Party for all reasonable expenses (including reasonable fees and expenses of counsel) as they
are incurred in connection with investigating, preparing, pursuing or defending any such action whether or not pending or threatened
and whether or not any Purchaser Party is a party, provided that the Company will not be responsible for any losses, claims, damages
or liabilities (or expense relating thereto) that are judicially determined in a judgment not subject to appeal to have resulted from
the bad faith, gross negligence or intentional misconduct of any Purchaser Party. If any action shall be brought against any Purchaser
Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company
in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable
to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the
defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that
(i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable
period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel, a
material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the
Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be
liable to any Purchaser Party under this Agreement (y) for any settlement by Purchaser Party effected without the Company&rsquo;s prior
written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim,
damage or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations, warranties, covenants or agreements
made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification required by this Section 4.10
shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received
or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser
Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11
<U>Reservation of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep
available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company
to issue Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12
<U>Participation in Future Financing</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
From the date hereof upon any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents for cash
consideration, Indebtedness or a combination of units thereof (a &ldquo;<U>Subsequent Financing</U>&rdquo;), the Purchasers shall have
the right to participate in the Subsequent Financing in an aggregate amount of up to 51% of the aggregate amount raised thereunder (the
&ldquo;<U>Participation Maximum</U>&rdquo;) on the same terms, conditions and price provided for in the Subsequent Financing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
At least five (5) Trading Days prior to the closing of the Subsequent Financing, the Company shall deliver to the Purchasers a written
notice of its intention to effect a Subsequent Financing (&ldquo;<U>Pre-Notice</U>&rdquo;), which Pre-Notice shall ask each Purchaser
if it wants to review the details of such financing (such additional notice, a &ldquo;<U>Subsequent Financing Notice</U>&rdquo;). Upon
the request of a Purchaser, and only upon a request by a Purchaser, for a Subsequent Financing Notice, the Company shall promptly, but
no later than one (1) Trading Day after such request, deliver a Subsequent Financing Notice to such Purchaser. The Subsequent Financing
Notice shall describe in reasonable detail the proposed terms of such Subsequent Financing, the amount of proceeds intended to be raised
thereunder and the Person or Persons through or with whom such Subsequent Financing is proposed to be effected and shall include a term
sheet or similar document relating thereto as an attachment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
If a Purchaser desires to participate in such Subsequent Financing, it must provide written notice to the Company by not later than 5:30
p.m. (New York City time) on the fifth (5th) Trading Day after such Purchaser has received the Pre-Notice that such Purchaser is willing
to participate in the Subsequent Financing, the amount of such Purchaser&rsquo;s participation, and representing and warranting that
such Purchaser has such funds ready, willing, and available for investment on the terms set forth in the Subsequent Financing Notice.
If the Company receives no such notice from a Purchaser as of such fifth (5th) Trading Day, such Purchaser shall be deemed to have notified
the Company that it does not elect to participate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
If by 5:30 p.m. (New York City time) on the fifth (5th ) Trading Day after a Purchaser has received the Pre-Notice, notifications by
such Purchaser of its willingness to participate in the Subsequent Financing (or to cause their designees to participate) is, in the
aggregate, less than the Participation Maximum, then the Company may effect the remaining portion of such Subsequent Financing on the
terms and with the Persons set forth in the Subsequent Financing Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The Company must provide each Purchaser with a second Subsequent Financing Notice, and each Purchaser will again have the right of participation
set forth above in this Section 4.12, if the Subsequent Financing subject to the initial Subsequent Financing Notice is not consummated
for any reason on the terms set forth in such Subsequent Financing Notice within thirty (30) Trading Days after the date of the initial
Subsequent Financing Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The Company and the Purchasers agree that if a Purchaser elects to participate in the Subsequent Financing, the transaction documents
related to the Subsequent Financing shall not include any term or provision that, directly or indirectly, will, or is intended to, exclude
the Purchasers from participating in a Subsequent Financing, including, but not limited to, provisions whereby any Purchaser shall be
required to agree to any restrictions on trading as to any securities of the Company or be required to consent to any amendment to or
termination of, or grant any waiver, release or the like under or in connection with, this Agreement, without the prior written consent
of such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<FONT STYLE="font-weight: normal">Notwithstanding anything to the contrary in this Section 4.12 and unless otherwise agreed to by the
Purchasers, the Company shall either confirm in writing to the Purchasers that the transaction with respect to the Subsequent Financing
has been abandoned or shall publicly disclose its intention to issue the securities in the Subsequent Financing, in either case in such
a manner such that the Purchasers will not be in possession of any material, non-public information, by the tenth (10th) Business Day
following delivery of the Subsequent Financing Notice. If by such tenth (10th) Business Day, no public disclosure regarding a transaction
with respect to the Subsequent Financing has been made, and no notice regarding the abandonment of such transaction has been received
by the Purchasers, such transaction shall be deemed to have been abandoned and the Purchasers shall not be deemed to be in possession
of any material, non-public information with respect to the Company or any of its Subsidiaries.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Notwithstanding the foregoing, this Section 4.12 shall not apply in respect of an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13
<U>Subsequent Equity Sales</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
From the date hereof until the 90<SUP>th</SUP> day following the Closing Date, neither the Company nor any Subsidiary shall (i) issue,
enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents
or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the
Registration Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
From the date hereof until such time as no Purchaser holds any of the Securities, the Company shall be prohibited from effecting or entering
into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a
combination of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction
in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or
include the right to receive, additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or
other price that is based upon, and/or varies with, the trading prices of or quotations for the shares of Common Stock at any time after
the initial issuance of such debt or equity securities or (B) with a conversion, exercise or exchange price that is subject to being
reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent
events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects
a transaction under, any agreement, including, but not limited to, an equity line of credit, whereby the Company may issue securities
at a future determined price. Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any such issuance,
which remedy shall be in addition to any right to collect damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding the foregoing, this Section 4.13 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction
shall be an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15
<U>Certain Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that
neither it, nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including
Short Sales, of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at
such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as
described in Section 4.6. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the
transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described
in Section 4.6, such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included
in the Disclosure Schedules. Notwithstanding the foregoing, and notwithstanding anything contained in this Agreement to the contrary,
the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that it will
not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this Agreement
are first publicly announced pursuant to the initial press release as described in Section 4.6, (ii) no Purchaser shall be restricted
or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws from and
after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release
as described in Section 4.6 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the
Company to the Company or its Subsidiaries after the issuance of the initial press release as described in Section 4.6.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16
<U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17
<U>Form D; Blue Sky Filings</U>. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation
D and to provide a copy thereof, promptly upon request of Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at Closing under
applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States, and shall provide evidence of such actions promptly
upon request of any Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
5</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MISCELLANEOUS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Termination</U>. This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without
any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the
Closing has not been consummated on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof, <U>provided</U>, <U>however</U>,
that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Fees and Expenses</U>. At the Closing, the Company has agreed to pay to the Purchasers an aggregate of $50,000 representing their
legal fees and expenses. The Company shall deliver to Purchaser, prior to each Closing, a completed and executed copy of the Closing
Statement, attached hereto as <U>Annex A</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party
shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such
party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer
Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company
and any conversion or exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the
delivery of any Securities to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding
of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is
delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached
hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such
notice or communication is delivered via facsimile at the facsimile number or email attachment as set forth on the signature pages attached
hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>)
Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt
by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the
signature pages attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Securities based
on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver,
by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver
disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser
(or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition or requirement of
this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner
impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the
rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require the prior
written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon
each Purchaser and holder of Securities and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the
transferred Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<U>No Third Party Beneficiaries</U>. The Placement Agent shall be the third-party beneficiary of the representations and warranties of
the Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the
benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision
hereof be enforced by, any other Person, except as otherwise set forth in Section 4.10 and this Section 5.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement, and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto
or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in Broward County, Florida. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in Broward County, Florida for the adjudication of any dispute hereunder or in connection herewith
or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction
Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding.
Each party hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process
and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition
to the obligations of the Company under Section 4.10, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing
party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation and prosecution
of such Action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<U>Survival</U>. The representations and warranties contained herein shall survive each Closing and the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party
executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo; signature
page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions
of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission
of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded
exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and
the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance
of a replacement warrant certificate evidencing such restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14
<U>Replacement of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
<U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction
Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that
a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16
<U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by
or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17
<U>Independent Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document
are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other
Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as
a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way
acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of
this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional
party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation
of the Transaction Documents. For reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to
communicate with the Company through the legal counsel of the Placement Agent. The legal counsel of the Placement Agent does not represent
any of the Purchasers and only represents the Placement Agent. The Company has elected to provide all Purchasers with the same terms
and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers.
It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between
the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18
<U>Liquidated Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts
have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20
<U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each
and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21
<B><U>WAIVER OF JURY TRIAL</U>. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY,
THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 39; Options: NewSection; Value: 39 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Progressive
    Care Inc.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice:</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">400
                                            Ansin Blvd Hallandale Beach, FL 33009</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
    a copy to (which shall not constitute notice):</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURE
PAGE FOR PURCHASER FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 39 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">PURCHASER
SIGNATURE PAGES TO Progressive Care Inc.<BR>
SECURITIES PURCHASE AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned has caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Purchaser:</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextPlat
    Corp</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
    of Authorized Signatory of Purchaser</I>:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Authorized Signatory:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles
    M. Fernandez</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Authorized Signatory:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Chairman and &nbsp;Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
Address of Authorized Signatory:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>cfernandez@nextplat.com
    </U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for Notice to Purchaser:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3250
    Mary St., Suite 410 Coconut Grove, FL 33133</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for Delivery of Securities to Purchaser (if not same as address for notice):</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
    Amount:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,000,000</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of Common Stock issuable:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">455,000</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Warrants issuable:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">455,000</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIN
    Number:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">65-0783722</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 39 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annex
A </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CLOSING
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the attached Securities Purchase Agreement, dated as of the date hereto, the Purchasers shall purchase 455,000 Units (each Unit consisting
of one share of Common Stock and one Warrant to purchase one (1) share of Common Stock) for $1,000,000 from Progressive Care Inc., a
Delaware corporation (the &ldquo;<U>Company</U>&rdquo;). All funds will be wired into an account maintained by the Company. All funds
will be disbursed in accordance with this Closing Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 89.7pt; text-align: justify; text-indent: -89.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disbursement
Date:</B> [_____], 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 89.7pt; text-align: justify; text-indent: -89.7pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>I.
                                            <U>PURCHASE PRICE</U></B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 80%; font-weight: bold; text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Gross
    Proceeds to be Received</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>II.
    <U>DISBURSEMENTS</U></B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Amount Disbursed:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-decoration: underline; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>WIRE
                                            INSTRUCTIONS</U>:</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
                                            see attached.</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acknowledged
and agreed to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this
___ day of _________, _____</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROGRESSIVE
    CARE INC. </FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    </I></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 42; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex10-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROGRESSIVE
CARE INC. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMON
STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 60%">Warrant Shares: 455,000</TD>
    <TD STYLE="white-space: nowrap; width: 20%; text-align: left">Initial Exercise Date:</TD>
    <TD STYLE="width: 20%"> May 9, 2023</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left"></TD>
    <TD STYLE="text-align: left">Issue Date:</TD>
    <TD>May 9, 2023</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, NEXTPLAT CORP or its assigns (the
&ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set
forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York
City time) on May 9, 2026 (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Progressive
Care Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to 455,000 shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant
Shares</U>&rdquo;) of the Company&rsquo;s common stock, par value $0.0001 per share (&ldquo;<U>Common Stock</U>&rdquo;). The purchase
price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated May 5, 2023 among the Company and the purchasers signatory
thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy
or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of
Exercise</U>&rdquo;). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement
Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise
Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States
bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the
date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a
portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$2.20</B>, subject to adjustment hereunder (the
&ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Cashless
Exercise</U>. This Warrant may be exercised, in whole or in part, by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall
be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 1in">&nbsp;</TD>
<TD STYLE="vertical-align: top; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">= as applicable:
(i) the closing price of one share of the Company&rsquo;s Common Stock on the Trading Day immediately preceding the date of the applicable
Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not
a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular
trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day,
or (ii) the closing price on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and
such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo;
on such Trading Day;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 1in">&nbsp;</TD>
<TD STYLE="vertical-align: top; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">= the Exercise
Price of this Warrant, as adjusted hereunder; and</FONT></TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
    <TD>&nbsp;</TD>
<TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
    <TD>&nbsp;</TD>
<TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">= the total number
of Warrant Shares that the Holder has elected to exercise in the Notice of Exercise if such exercise were by means of a cash exercise
rather than a cashless exercise.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant
Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this
Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything herein to the contrary, in no event shall more than 455,000 Warrant Shares (as such number may be adjusted pursuant to Section
3) be issued if the cashless exercise mechanism pursuant to this Section 2(c) is elected by the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless
exercise pursuant to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mechanics
                                            of Exercise</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust
Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such
system and either (A) there is an effective registration statement registering the issuance of the Warrant Shares to or resale of the
Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in
the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is
entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest
of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the
aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery
to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice
of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect
to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the
number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for
any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company
shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise
(based on the closing price of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to
$20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery
Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is
a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement
Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading
Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. The Holder shall provide
the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence
of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder,
at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s
failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Subsequent
Equity Sales</U>. If the Company or any Subsidiary thereof, as applicable, at any time while this Warrant is outstanding, shall sell,
enter into an agreement to sell, or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue
(or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock or Common Stock Equivalents, at
an effective price per share less than the Exercise Price then in effect (such lower price, the &ldquo;<U>Base Share Price</U>&rdquo;
and such issuances collectively, a &ldquo;<U>Dilutive Issuance</U>&rdquo;) (it being understood and agreed that if the holder of the
Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset provisions,
floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection
with such issuance, be entitled to receive shares of Common Stock at an effective price per share that is less than the Exercise Price,
such issuance shall be deemed to have occurred for less than the Exercise Price on such date of the Dilutive Issuance at such effective
price), then simultaneously with the consummation (or, if earlier, the announcement) of each Dilutive Issuance the Exercise Price shall
be reduced to equal the Base Share Price. Notwithstanding the foregoing, no adjustments shall be made, paid or issued under this Section
3(b) in respect of an Exempt Issuance. The Company shall notify the Holder, in writing, no later than the Trading Day following the issuance
or deemed issuance of any Common Stock or Common Stock Equivalents subject to this Section 3(b), indicating therein the applicable issuance
price, or applicable reset price, exchange price, conversion price and other pricing terms (such notice, the &ldquo;<U>Dilutive Issuance
Notice</U>&rdquo;). For purposes of clarification, whether or not the Company provides a Dilutive Issuance Notice pursuant to this Section
3(b), upon the occurrence of any Dilutive Issuance, the Holder is entitled to receive a number of Warrant Shares based upon the Base
Share Price regardless of whether the Holder accurately refers to the Base Share Price in the Notice of Exercise. If the Company enters
into a Variable Rate Transaction, the Company shall be deemed to have issued Common Stock or Common Stock Equivalents at the lowest possible
price, conversion price or exercise price at which such securities may be issued, converted or exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Subsequent
Rights Offerings</U>. If the Company, at any time while the Warrant is outstanding, shall issue rights, options or warrants to all holders
of Common Stock (and not to the Holder) entitling them to subscribe for or purchase shares of Common Stock at a price per share less
than the closing price on the record date mentioned below, then the Exercise Price shall be multiplied by a fraction, of which the denominator
shall be the number of shares of the Common Stock outstanding on the date of issuance of such rights, options or warrants plus the number
of additional shares of Common Stock offered for subscription or purchase, and of which the numerator shall be the number of shares of
the Common Stock outstanding on the date of issuance of such rights, options or warrants plus the number of shares which the aggregate
offering price of the total number of shares so offered (assuming receipt by the Company in full of all consideration payable upon exercise
of such rights, options or warrants) would purchase at such closing price. Such adjustment shall be made whenever such rights, options
or warrants are issued, and shall become effective immediately after the record date for the determination of stockholders entitled to
receive such rights, options or warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Pro
Rata Distributions</U>. If the Company, at any time while this Warrant is outstanding, shall distribute to all holders of Common Stock
(and not to the Holder) evidences of its indebtedness or assets (including cash and cash dividends) or rights or warrants to subscribe
for or purchase any security other than the Common Stock (which shall be subject to Section 3(b)), then in each such case the Exercise
Price shall be adjusted by multiplying the Exercise Price in effect immediately prior to the record date fixed for determination of stockholders
entitled to receive such distribution by a fraction of which the denominator shall be the closing price determined as of the record date
mentioned above, and of which the numerator shall be such closing price on such record date less the then per share fair market value
at such record date of the portion of such assets or evidence of indebtedness or rights or warrants so distributed applicable to one
outstanding share of the Common Stock, as determined by the Board of Directors in good faith. In either case the adjustments shall be
described in a statement provided to the Holder of the portion of assets or evidences of indebtedness so distributed or such subscription
rights applicable to one share of Common Stock. Such adjustment shall be made whenever any such distribution is made and shall become
effective immediately after the record date mentioned above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in
one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the
Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares
for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the
Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock
or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 30% of
the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or
party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business
combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall
receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the
&ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares
of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation
in Section 2(e) on the exercise of this Warrant), as adjusted in accordance with provisions of this Warrant. If holders of Common Stock
are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given
the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor
Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents
in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to
the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of
the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor
Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without
regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies
the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock
pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such
exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity),
and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the
other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Notice
to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock and/or Common Stock,
(C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares
of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at
its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior
to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for
the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the
holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined
or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective
or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares
of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer
or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect
the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant
constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously
file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant
during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise
be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant, subject to the prior written consent of the Holder, reduce the then current Exercise Price to any amount and for any period
of time deemed appropriate by the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of
the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical
with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Authorized
Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the
issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance
of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares
upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to
assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements
of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon
the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant
and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free
from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer
occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of
this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which
results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs
and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the
Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered
in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>PROGRESSIVE
    CARE INC.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></P></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To: [_______________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) Payment
shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] [if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ___________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _______________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
___________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify">________________________________________________<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U> </U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________________________________________<U> </U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Phone
    Number:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">________________________________________________</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Email
    Address:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">________________________________________________</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature:_________________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:_________________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ex10-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DEBT
CONVERSION AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Debt Conversion Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of May 9, 2023 between Progressive Care Inc., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), and each holder identified on the signature pages hereto (each, a &ldquo;<U>Holder</U>&rdquo;
and together, the &ldquo;<U>Holders</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
pursuant to that certain Amended and Restated Secured Convertible Promissory Note, dated as of September 2, 2022, in the original face
amount of $2,790,885.63 (the &ldquo;<U>Note</U>&rdquo;), made by the Company for the benefit of the lenders identified on the signature
pages thereto (including the Holders, the &ldquo;<U>Lenders</U>&rdquo;), the total accrued and unpaid principal and interest payable
to the Lenders under the Note as of the date of this Agreement is $2,887,228.53. Capitalized terms used, but not otherwise defined herein,
shall have the meanings ascribed to them in the Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
of the total $2,887,228.53 accrued and unpaid principal and interest payable to the Lenders under the Note as of the date of this Agreement,
each Holder is owed the portion set forth on its signature page hereto (each, a &ldquo;<U>Pro Rata Amount</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Company has advised the Holders that it intends to sell 455,000 units (each a &ldquo;<U>Unit</U>&rdquo;) in a private placement (the
&ldquo;<U>Placement</U>&rdquo;) at $2.20 per Unit, each Unit to consist of one share of Common Stock and a warrant to purchase one share
of Common Stock at a purchase price of $2.20 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the agent for the Placement has imposed as a pre-condition to the Placement the conversion by Holders of their respective portions of
the Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
if the Holders were to wait to convert their portion of the Note into Common Stock until after completion of the Placement they would
be entitled to the benefit of an improved conversion rate as a result of the Placement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
to induce the Holders to agree to the conversion at the present time, the Company is willing to issue a Common Stock Purchase Warrant
in the form attached hereto as <U>Exhibit A</U> (each, a &ldquo;<U>Warrant</U>&rdquo;), to each Holder exercisable for a number of shares
of Common Stock equal to the number of Conversion Shares to be issued to such Holder upon conversion of its portion of the Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
each Holder is willing to convert its portion of Note on the terms set forth below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree
as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. <U>Conversion</U>.
Each Holder hereby agrees to submit for conversion its Pro Rata Amount under the Note, such conversion to be contingent upon, and to
take place contemporaneously with, the closing of the Placement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <U>Conversion
Price</U>. The Company and each Holder agree that the &ldquo;Conversion Price&rdquo; as that term is defined in Note, for purposes of
the conversion contemplated hereby shall be $2.20 per Conversion Share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <U>Warrants</U>.
The Company shall issue a Warrant to each Holder exercisable for a number of shares of Common Stock equal to the number of Conversion
Shares to be issued to such Holder upon conversion of its portion of the Note. The Warrants will be in substantially the same form as
the warrants issued in the Placement, will have a five year term from the date of this Agreement and will have an exercise price per
share of $2.20.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Remainder
of Page Intentionally Blank. Signature Pages Follow.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have executed this Debt Conversion Agreement as of the date first set forth above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-weight: bold">COMPANY:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-weight: bold">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2">Progressive Care Inc.</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 45%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Name:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Title:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned Holder has executed this Debt Conversion Agreement as of the date first set forth above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="3" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Holder:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
    of Authorized Signatory of Holder:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Authorized Signatory:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Authorized Signatory:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address of Authorized Signatory:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro Rata Amount:</FONT></P>
                                                         <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
be completed by the Company)</I></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>ex10-4.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROGRESSIVE
CARE INC. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMON
STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: [<FONT>_______</FONT>]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    Exercise Date: May [_], 2023</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    [_], 2023</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, [<FONT>______</FONT>]
or his or its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or
prior to 5:00 p.m. (New York City time) on May [__], 2026 (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe
for and purchase from Progressive Care Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to [<FONT>____</FONT>]
shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of the Company&rsquo;s common stock, par value $0.001
per share (&ldquo;<U>Common Stock</U>&rdquo;). The purchase price of one share of Common Stock under this Warrant shall be equal to the
Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy
or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of
Exercise</U>&rdquo;). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement
Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise
Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States
bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the
date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a
portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$2.20</B>, subject to adjustment hereunder (the
&ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Cashless
Exercise</U>. This Warrant may be exercised, in whole or in part, by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall
be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 0.5in; vertical-align: top">(A) =</TD>
    <TD STYLE="text-align: justify"> as applicable: (i) the closing price of one share of the Company&rsquo;s Common Stock on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, or (ii) the closing price on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>(B) =</TD>
    <TD STYLE="text-align: justify"> the Exercise Price of this Warrant, as adjusted hereunder; and</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top">(X) =</TD>
    <TD STYLE="text-align: justify"> the total number of Warrant Shares that the Holder has elected to exercise in the Notice of Exercise if such exercise were by means of a cash exercise rather than a cashless exercise.</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant
Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this
Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything herein to the contrary, in no event shall more than [<FONT>________</FONT>] Warrant Shares
(as such number may be adjusted pursuant to Section 3) be issued if the cashless exercise mechanism pursuant to this Section 2(c) is
elected by the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless
exercise pursuant to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mechanics
                                            of Exercise</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust
Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such
system and either (A) there is an effective registration statement registering the issuance of the Warrant Shares to or resale of the
Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in
the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is
entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest
of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the
aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery
to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice
of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect
to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the
number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for
any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company
shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise
(based on the closing price of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to
$20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery
Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is
a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement
Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading
Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. The Holder shall provide
the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence
of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder,
at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s
failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Subsequent
Equity Sales</U>. If the Company or any Subsidiary thereof, as applicable, at any time while this Warrant is outstanding, shall sell,
enter into an agreement to sell, or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue
(or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock or Common Stock Equivalents, at
an effective price per share less than the Exercise Price then in effect (such lower price, the &ldquo;<U>Base Share Price</U>&rdquo;
and such issuances collectively, a &ldquo;<U>Dilutive Issuance</U>&rdquo;) (it being understood and agreed that if the holder of the
Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset provisions,
floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection
with such issuance, be entitled to receive shares of Common Stock at an effective price per share that is less than the Exercise Price,
such issuance shall be deemed to have occurred for less than the Exercise Price on such date of the Dilutive Issuance at such effective
price), then simultaneously with the consummation (or, if earlier, the announcement) of each Dilutive Issuance the Exercise Price shall
be reduced to equal the Base Share Price. Notwithstanding the foregoing, no adjustments shall be made, paid or issued under this Section
3(b) in respect of an Exempt Issuance. The Company shall notify the Holder, in writing, no later than the Trading Day following the issuance
or deemed issuance of any Common Stock or Common Stock Equivalents subject to this Section 3(b), indicating therein the applicable issuance
price, or applicable reset price, exchange price, conversion price and other pricing terms (such notice, the &ldquo;<U>Dilutive Issuance
Notice</U>&rdquo;). For purposes of clarification, whether or not the Company provides a Dilutive Issuance Notice pursuant to this Section
3(b), upon the occurrence of any Dilutive Issuance, the Holder is entitled to receive a number of Warrant Shares based upon the Base
Share Price regardless of whether the Holder accurately refers to the Base Share Price in the Notice of Exercise. If the Company enters
into a Variable Rate Transaction, the Company shall be deemed to have issued Common Stock or Common Stock Equivalents at the lowest possible
price, conversion price or exercise price at which such securities may be issued, converted or exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Subsequent
Rights Offerings</U>. If the Company, at any time while the Warrant is outstanding, shall issue rights, options or warrants to all holders
of Common Stock (and not to the Holder) entitling them to subscribe for or purchase shares of Common Stock at a price per share less
than the closing price on the record date mentioned below, then the Exercise Price shall be multiplied by a fraction, of which the denominator
shall be the number of shares of the Common Stock outstanding on the date of issuance of such rights, options or warrants plus the number
of additional shares of Common Stock offered for subscription or purchase, and of which the numerator shall be the number of shares of
the Common Stock outstanding on the date of issuance of such rights, options or warrants plus the number of shares which the aggregate
offering price of the total number of shares so offered (assuming receipt by the Company in full of all consideration payable upon exercise
of such rights, options or warrants) would purchase at such closing price. Such adjustment shall be made whenever such rights, options
or warrants are issued, and shall become effective immediately after the record date for the determination of stockholders entitled to
receive such rights, options or warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Pro
Rata Distributions</U>. If the Company, at any time while this Warrant is outstanding, shall distribute to all holders of Common Stock
(and not to the Holder) evidences of its indebtedness or assets (including cash and cash dividends) or rights or warrants to subscribe
for or purchase any security other than the Common Stock (which shall be subject to Section 3(b)), then in each such case the Exercise
Price shall be adjusted by multiplying the Exercise Price in effect immediately prior to the record date fixed for determination of stockholders
entitled to receive such distribution by a fraction of which the denominator shall be the closing price determined as of the record date
mentioned above, and of which the numerator shall be such closing price on such record date less the then per share fair market value
at such record date of the portion of such assets or evidence of indebtedness or rights or warrants so distributed applicable to one
outstanding share of the Common Stock, as determined by the Board of Directors in good faith. In either case the adjustments shall be
described in a statement provided to the Holder of the portion of assets or evidences of indebtedness so distributed or such subscription
rights applicable to one share of Common Stock. Such adjustment shall be made whenever any such distribution is made and shall become
effective immediately after the record date mentioned above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in
one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the
Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares
for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the
Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock
or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 30% of
the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or
party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business
combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall
receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the
&ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares
of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation
in Section 2(e) on the exercise of this Warrant), as adjusted in accordance with provisions of this Warrant. If holders of Common Stock
are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given
the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor
Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents
in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to
the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of
the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor
Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without
regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies
the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock
pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such
exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity),
and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the
other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Notice
to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock and/or Common Stock,
(C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares
of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at
its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior
to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for
the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the
holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined
or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective
or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares
of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer
or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect
the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant
constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously
file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant
during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise
be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant, subject to the prior written consent of the Holder, reduce the then current Exercise Price to any amount and for any period
of time deemed appropriate by the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof, this Warrant and all rights
hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant
at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the
form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon
the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant
or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant
to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this
Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant
Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical
with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, an unqualified opinion of counsel issued to the Company and reasonably acceptable to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Authorized
Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the
issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance
of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares
upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to
assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements
of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon
the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant
and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free
from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer
occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Jurisdiction</U>.
This Warrant shall be governed by the laws of the State of New York without regard for its conflict of laws principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of
this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material
damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including,
but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting
any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered
in accordance with the notice and delivery instructions provided to the Company by the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a
part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>PROGRESSIVE
    CARE INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:
[_______________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if
any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;
] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;
] [if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify">__<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>__________________________________________</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>______________________________________</U></FONT>_____</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
                                            Print)</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT>____</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT>____</P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:<U>_________________</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:<U>__________________</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>6
<FILENAME>ex10-5.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.5</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FIRST
AMENDMENT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
<B>First Amendment to Securities Purchase Agreement</B> (this &ldquo;<U>Amendment</U>&rdquo;) is entered into as of this May 9, 2023
by and between Progressive Care Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;) and NextPlat Corp, a Nevada corporation
(&ldquo;<U>Purchaser</U>&rdquo;). The Company and Purchaser are sometimes individually referred to in this Amendment as a &ldquo;<U>Party</U>&rdquo;
and collectively as the &ldquo;<U>Parties.</U>&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RECITALS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
on November 16, 2022, the Company and the Purchaser entered into a Securities Purchase Agreement pursuant to which the Company has agreed
to issue, and Purchaser has agreed to purchase, from time to time during the three year term of the SPA, up to an aggregate of $10 million
of secured convertible debentures from the Company (the &ldquo;<U>Agreement</U>&rdquo;). Capitalized terms not otherwise defined in this
Amendment shall have the meaning set forth in the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
in accordance with Section 5.5 of the Agreement, the Parties wish to amend the Agreement as set forth in this Amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW
THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties hereby agree
to amend the Agreement as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. &nbsp;<B><U>Amendments to Agreement</U>. </B>The Agreement is hereby amended as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
definition of &ldquo;Debentures&rdquo; in Section 1.1 of the Agreement is hereby deleted in its entirety and replaced with the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;<U>Debentures</U>&rdquo;
means the Original Issue Discount Convertible Debentures to be issued by the Company to the Purchaser hereunder, due, subject to the
terms therein, three (3) years from their date of issuance, convertible as provided therein, in whole or in part, at the option of the
Purchaser at a conversion price of $2.20 per share of the Company&rsquo;s common stock, subject to adjustment as provided in the form
of Debenture, and in all material respects in the form of <U>Exhibit A</U> attached hereto.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
&ldquo;Original Conversion Price&rdquo; listed on the face of the Form of Debenture included at Exhibit A of the Agreement is hereby
deleted and replaced with the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Original
Conversion Price (subject to adjustment herein): $2.20</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Section
4(b) of the Form of Debenture included at Exhibit A of the Agreement is hereby deleted and replaced with the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(b) <U>Conversion
Price</U>. The conversion price in effect on any Conversion Date shall be equal to $2.20 per Common Share, subject to adjustment herein
(the &ldquo;<U>Conversion Price</U>&rdquo;).</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <B><U>No
Other Amendments and No Waiver</U>.</B> Except as otherwise expressly set forth in this Amendment, the Agreement shall remain in full
force and effect without change or modification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <B><U>Headings</U></B>. The headings herein are for convenience only, do not constitute a part
of this Amendment and shall not be deemed to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. <B><U>Governing Law</U></B>. This Amendment shall be governed by and construed in accordance
with the Laws of the State of New York (regardless of the laws that might otherwise govern under applicable principles of conflicts of
laws thereof) as to all matters, including matters of validity, construction, effect, performance and remedies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. <B><U>Execution</U></B>. This Amendment may be executed in counterparts, each of which shall
be deemed to be an original, but all of which shall constitute one and the same agreement. Delivery of an executed counterpart of a signature
page to this Amendment by facsimile or e-mail transmission shall be as effective as delivery of a manually executed counterpart of this
Amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>**Signatures
on Next Page**</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF, </B>the undersigned parties have caused this Amendment to be executed as of the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMPANY:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROGRESSIVE
    CARE INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURCHASER:
    </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NEXTPLAT
    CORP</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROGRESSIVE
CARE INC. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMON
STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 60%">Warrant
Shares: [_______]</TD>
    <TD STYLE="white-space: nowrap; width: 20%; text-align: left"> Initial Exercise Date:</TD>
    <TD STYLE="width: 20%"> May [_], 2023</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left"></TD>
    <TD STYLE="text-align: left">Issue Date:</TD>
    <TD>May [_], 2023</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, [______] or his assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on May [__], 2026
(the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Progressive Care Inc., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), up to [____] shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;)
of the Company&rsquo;s common stock, par value $0.001 per share (&ldquo;<U>Common Stock</U>&rdquo;). The purchase price of one share
of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Reserved</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile
copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice
of Exercise</U>&rdquo;). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement
Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise
Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States
bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the
date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a
portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$2.20</B>, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. This Warrant may be exercised, in whole or in part, by means of a &ldquo;cashless exercise&rdquo; in which
the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=
  as applicable: (i) the closing price of one share of the Company&rsquo;s Common Stock on the Trading Day immediately preceding the
  date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof
  on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the
  opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
  laws) on such Trading Day, or (ii) the closing price on the date of the applicable Notice of Exercise if the date of such Notice of
  Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close
  of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>

<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=
  the Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>

<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=
  the total number of Warrant Shares that the Holder has elected to exercise in the Notice of Exercise if such exercise were by means
  of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant
Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this
Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything herein to the contrary, in no event shall more than [________] Warrant Shares (as such number may be adjusted pursuant to Section
3) be issued if the cashless exercise mechanism pursuant to this Section 2(c) is elected by the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless
exercise pursuant to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement registering the issuance of the Warrant Shares to or resale
of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale
limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered
in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder
is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest
of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the
aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery
to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice
of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect
to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the
number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for
any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company
shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise
(based on the closing price of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to
$20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery
Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is
a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement
Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading
Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. The Holder shall provide
the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence
of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder,
at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s
failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Equity Sales</U>. If the Company or any Subsidiary thereof, as applicable, at any time while this Warrant is outstanding,
shall sell, enter into an agreement to sell, or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose
of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock or Common Stock Equivalents,
at an effective price per share less than the Exercise Price then in effect (such lower price, the &ldquo;<U>Base Share Price</U>&rdquo;
and such issuances collectively, a &ldquo;<U>Dilutive Issuance</U>&rdquo;) (it being understood and agreed that if the holder of the
Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset provisions,
floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection
with such issuance, be entitled to receive shares of Common Stock at an effective price per share that is less than the Exercise Price,
such issuance shall be deemed to have occurred for less than the Exercise Price on such date of the Dilutive Issuance at such effective
price), then simultaneously with the consummation (or, if earlier, the announcement) of each Dilutive Issuance the Exercise Price shall
be reduced to equal the Base Share Price. Notwithstanding the foregoing, no adjustments shall be made, paid or issued under this Section
3(b) in respect of an Exempt Issuance. The Company shall notify the Holder, in writing, no later than the Trading Day following the issuance
or deemed issuance of any Common Stock or Common Stock Equivalents subject to this Section 3(b), indicating therein the applicable issuance
price, or applicable reset price, exchange price, conversion price and other pricing terms (such notice, the &ldquo;<U>Dilutive Issuance
Notice</U>&rdquo;). For purposes of clarification, whether or not the Company provides a Dilutive Issuance Notice pursuant to this Section
3(b), upon the occurrence of any Dilutive Issuance, the Holder is entitled to receive a number of Warrant Shares based upon the Base
Share Price regardless of whether the Holder accurately refers to the Base Share Price in the Notice of Exercise. If the Company enters
into a Variable Rate Transaction, the Company shall be deemed to have issued Common Stock or Common Stock Equivalents at the lowest possible
price, conversion price or exercise price at which such securities may be issued, converted or exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Subsequent Rights Offerings</U>. If the Company, at any time while the Warrant is outstanding, shall issue rights, options or warrants
to all holders of Common Stock (and not to the Holder) entitling them to subscribe for or purchase shares of Common Stock at a price
per share less than the closing price on the record date mentioned below, then the Exercise Price shall be multiplied by a fraction,
of which the denominator shall be the number of shares of the Common Stock outstanding on the date of issuance of such rights, options
or warrants plus the number of additional shares of Common Stock offered for subscription or purchase, and of which the numerator shall
be the number of shares of the Common Stock outstanding on the date of issuance of such rights, options or warrants plus the number of
shares which the aggregate offering price of the total number of shares so offered (assuming receipt by the Company in full of all consideration
payable upon exercise of such rights, options or warrants) would purchase at such closing price. Such adjustment shall be made whenever
such rights, options or warrants are issued, and shall become effective immediately after the record date for the determination of stockholders
entitled to receive such rights, options or warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Pro Rata Distributions</U>. If the Company, at any time while this Warrant is outstanding, shall distribute to all holders of Common
Stock (and not to the Holder) evidences of its indebtedness or assets (including cash and cash dividends) or rights or warrants to subscribe
for or purchase any security other than the Common Stock (which shall be subject to Section 3(b)), then in each such case the Exercise
Price shall be adjusted by multiplying the Exercise Price in effect immediately prior to the record date fixed for determination of stockholders
entitled to receive such distribution by a fraction of which the denominator shall be the closing price determined as of the record date
mentioned above, and of which the numerator shall be such closing price on such record date less the then per share fair market value
at such record date of the portion of such assets or evidence of indebtedness or rights or warrants so distributed applicable to one
outstanding share of the Common Stock, as determined by the Board of Directors in good faith. In either case the adjustments shall be
described in a statement provided to the Holder of the portion of assets or evidences of indebtedness so distributed or such subscription
rights applicable to one share of Common Stock. Such adjustment shall be made whenever any such distribution is made and shall become
effective immediately after the record date mentioned above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary),
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding
Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization
or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted
into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions
consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization,
spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than
30% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making
or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business
combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall
receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the
&ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares
of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation
in Section 2(e) on the exercise of this Warrant), as adjusted in accordance with provisions of this Warrant. If holders of Common Stock
are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given
the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor
Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents
in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to
the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of
the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor
Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without
regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies
the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock
pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such
exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity),
and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the
other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock and/or Common
Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase
any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection
with any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party,
any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted
into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or
winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder
at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days
prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken
for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which
the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined
or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective
or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares
of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer
or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect
the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant
constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously
file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant
during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise
be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during
the term of this Warrant, subject to the prior written consent of the Holder, reduce the then current Exercise Price to any amount and
for any period of time deemed appropriate by the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof,
this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of
this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay
any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute
and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue Date and
shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Transfer Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public
information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or
transferee of this Warrant, as the case may be, an unqualified opinion of counsel issued to the Company and reasonably acceptable to
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the
issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance
of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares
upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to
assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements
of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon
the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant
and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free
from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer
occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. This Warrant shall be governed by the laws of the State of New York without regard for its conflict of laws principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material
damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including,
but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting
any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice and delivery instructions provided to the Company by the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>PROGRESSIVE
    CARE INC. </B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:
[_______________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
] [if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 1in; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ___________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _______________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
___________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">______________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
                                            Print)</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>8
<FILENAME>ex99-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-2_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NextPlat
Strengthens Ties to Progressive Care Inc. Investing an additional $1 Million; and Explores the Possible Spinoff of its Global
Telesat and Orbital Satcom Business Units</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COCONUT
GROVE, FL &ndash; May 11<FONT STYLE="background-color: white">, 2023 </FONT></B><FONT STYLE="background-color: white">&ndash; NextPlat
Corp (<U>NASDAQ: NXPL, NXPLW</U>) (&ldquo;NextPlat&rdquo; or the &ldquo;Company&rdquo;), a global e-commerce provider today announced
that it has completed an additional $1 million investment in Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services
and technology company (&ldquo;Progressive Care&rdquo;).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
connection with the $1 million investment, NextPlat purchased 455,000 newly issued Units of Progressive Care, with each Unit comprised
of one share of Progressive Care&rsquo;s Common Stock and one Warrant to purchase a share of Common Stock at a per Unit purchase
price of $2.20. In addition, NextPlat Corp, </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Messrs.
<FONT STYLE="background-color: white">Fernandez and Barreto, and certain other holders of convertible note issued by Progressive Care
agreed to convert the approximately $2.9 million of outstanding principal and accrued and unpaid interest under the note to shares of
Progressive Care&rsquo;s Common Stock at a conversion price of $2.20 per share. Dawson James Securities Inc. served
as an advisor for this transaction. </FONT>ArentFox Schiff LLP, Washington, DC, acted as counsel to the Company in connection with the
transaction, and Lucosky Brookman, New York, NY, served as counsel to Progressive Care.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
transaction further solidifies NextPlat&rsquo;s position as a controlling shareholder of Progressive Care. Following the closing of the
transaction, NextPlat owns Progressive Care Common and Preferred Stock representing approximately 38.4% of Progressive Care&rsquo;s total
outstanding voting securities. The Company expects to exercise and/or convert such portion of its convertible and exercisable
Progressive Care securities to increase its equity holdings in Progressive Care to more than 50% of its issued and outstanding
voting securities. The Company expects that Progressive Care&rsquo;s pharmacy, healthcare services and technology businesses will
be an important component of the Company&rsquo;s continued evolution as a global e-commerce platform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Separately,
the Company has engaged Dawson James Securities, Inc. to advise the Company in connection with its consideration
of a possible spinoff of its Global Telesat Communications Ltd and Orbital Satcom Corp business units as the Company continues
its evolution as a global e-commerce and technology company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
NextPlat Corp</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextPlat
is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets for physical and digital assets.
The Company intends to collaborate with businesses, optimizing their ability to sell their goods online, domestically, and internationally,
and enabling customers and partners to optimize their e-commerce presence and revenue. NextPlat currently operates an e-commerce communications
services division through its Global Telesat Communications Ltd and Orbital Satcom Corp business units that offer voice, data, tracking,
and IoT services to customers worldwide through multiple global storefronts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Progressive
Care Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Progressive
Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals,
compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM),
the supply of prescription medications to long-term care facilities, and health practice risk management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
statements in this release constitute forward-looking statements. These statements include the capabilities and success of the Company&rsquo;s
business and any of its products, services or solutions. The words &ldquo;believe,&rdquo; &ldquo;forecast,&rdquo; &ldquo;project,&rdquo;
&ldquo;intend,&rdquo; &ldquo;expect,&rdquo; &ldquo;plan,&rdquo; &ldquo;should,&rdquo; &ldquo;would,&rdquo; and similar expressions and
all statements, which are not historical facts, are intended to identify forward-looking statements. These forward-looking statements
involve and are subject to known and unknown risks, uncertainties and other factors, including the Company&rsquo;s ability to launch
new data-driven tools and services and its ability to grow and expand as intended, any of which could cause the Company to not achieve
some or all of its goals or the Company&rsquo;s previously reported actual results, performance (finance or operating), including those
expressed or implied by such forward-looking statements. More detailed information about the Company and the risk factors that may affect
the realization of forward-looking statements is set forth in the Company&rsquo;s filings with the Securities and Exchange Commission
(the &ldquo;SEC&rdquo;), copies of which may be obtained from the SEC&rsquo;s website at www.sec.gov. The Company assumes no, and hereby
disclaims any, obligation to update the forward-looking statements contained in this press release.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Media
and Investor Contact for NextPlat Corp:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
Glickman</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MWGCO,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">917-397-2272</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">mike@mwgco.net</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex99-2_001.jpg
<TEXT>
begin 644 ex99-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  S -T# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4.#2_A25
MPOQ:^)VE_!WP/J/B;5DD>ULPNV&$?--(QVJB^]33C*I.,(*\I =E/<16L9>5
MU1%^9F8]*^9_BQ^VEH_A_5CX=\ V,WCGQ/,WE+'9*SV\;?[R_P"L_P" ?]]5
MY!K.I?$3]I+17\0^--?M_AC\*&&]4\W:]RG^ROWI?^!_+_=6E\ ^(I?W_AO]
MGGP<+>)?W5]XWUQ?F_WMS_=_W?\ QROKL+E=*C>=?WI+=7M%>K_1:FO*=)H_
M[8'Q(^&^I0)\7/ MS8Z+>'$6H6ELT;1?^/;6_P!WY6KZJ\"_$CP]\3-%CU3P
MWJUOJEDWWFA;YXS_ '67[RM]:^4+RW^+_@?29KB?5=+^.'AAQLU325V231?W
M]G\1_P _)7 ^%_!ND>*M5D\2_ ?Q1=>$O%\9WW/@_5)/*9O[RQLWWE_V7W?\
M KHQ&"PV*CS12@^\;N/S3U7KL5RGZ.TOX5\Q_LY_M.:IX\\477@#QMHYT3QM
M8QL[>6-J3[3\_P O\+?Q?W6'2OH2X\3:1:R-'-JEE#*ORLLERBLOX9KY'$8:
MIAZGLY[_ -:HP-JBJ\<RS1K(C*\3+N5EJI:Z]IM],8;;4+6XF'_+.&=7;\LU
MB!IT5CW'B32;.9X9]4LX9E^\DUPB,M+;^)-*OIE@M]4L[B5ONQPSHS-^&: -
M>BL:W\2:3>7"00ZI9S3MPL<,Z.S5<OM0MM-MS/=W$=O%]W=(VU: +M%8R^)M
M)DA>==4LWB5MK/\ :%VJWIFE_P"$JT3_ *#6G_\ @4G_ ,50!L45E6>O:;J4
MGE6NH6MS+MW;(9E=ORIG_"5:)_T&M/\ _ I/_BJ -BBJEK>07T/F6\T=Q&?X
MHV#+^E5+KQ%I=C<""ZU*TMYC_P LYIU1ORS0!K4444 %%8:^+]#9E5=;TYF;
MTND_^*K2FFCMXWEE98XE7<SLWRK0!:HK'_X2K1/^@UI__@4G_P 538?%&CS2
M)%%JUE+*QVJL=RC,WZT ;5%%% #*^9_^"@G_ ";_ '/_ &$+;_T)J^F*^9_^
M"@G_ ";_ '/_ &$+;_T)J]#+?][I^J&CR_XB^%;/XB_M#?"7P7JBD^&(=$6X
M_L]&VPL4C=MO_CB+_NUD:AXBNOB5HNN7NMZ_#\-/@WH.HOI2Z;H\>RXOF7^#
MY?[W_P 5\O\ %78ZA(L?[8'PJWLJ;O#K*G_?B6O*M)\*Q?$3X?>,OA?_ &E:
M:+XWB\3S:G;6.K?N/M*JK+M5O[WS5]I3Y9<JEHDHZ]KR=WZ^=M#H-/X;6O@+
MQQKBCX*^(]5^'GCBW5O(T_4VW6^JJOS?/]_^'_\ 9JO\3M8C\9?":#XFRZ7;
M^'_B'X=\0II=[J&F?NEG=/XL^E4/@)\"=>^"/CBS^(/Q$N;'P?HNBM.NR\N$
M>6Z9XGBVQ*O^_2:\LDW[)OBG4VADBM-8\9?:[%I5V^9$Y^^OZ_E7;B*=&EB;
M8>ISQO%<V^][J_56UMK86IZBTPN/V_/!]WM5)+C1EEEV_P 3-:RU^7G[9VCW
MVO?MD?%NUL+:2YFCUB\N&2,9.Q%WNW_?*U^H,:[?V[O :_\ 4 7_ -)I:^--
M#CBNO^"OVI6\R)-;7'BN\@EB==RNK0NK+^M?(YPE&5&W\D?S9E(^I/\ @E3^
MTC_PM#X'W_@#6;GS_$7A"/;:^:WSSV#?ZK_OAOD_[XKY;_X)2_\ )\'B3_L'
M:E_Z.6N4\8:7JG_!.?\ ;L%S:12MX7,_GP1M]V[TBY^5XO\ @'S+_O0K74_\
M$I9[:\_;9\0W5G)OM)-,U%X7V_>5ID*_I7SA!Y=^W)X?_P"$H_;Z\8Z']JBL
MO[2UNUM3=2_<B\U(EWM_N[OTK[,_91_X)NQ? WX]>'/&47Q=T'Q.VEM*_P#9
MME;!99=T3I_SU;^_7QM^V]X=_P"$M_X* >,-!^T+:?VIKEK9>>R[A'YJ1+N_
M\>K[U_9%_P"":MQ^S1\;M,\=/\1[/Q(EK;3P?88],^SNWFQ;-V[SGH ^5O\
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M]DM9OYI6"X^[OW;?X*]"_P""XG_(K?"7_K\U+_T"WKZF_P"";O\ R9?\-/\
MKSE_]*): /IFBBB@!E>*_M:?#?4_BI\&=3T?1%675(Y8KN"W/_+8QOG97M5&
M>M71JRP]2-6.\7<#\^(?$'AKXZ+H6E^)-4O_ (9_%[P[&EI97=PK113.O"CZ
M;_X?EZ_Q59\=:E/8K!HGQ]\*-<0J?*T_X@:"I\U/[K.R_>_A_P#B*^K?BU\!
M_!OQLT\P:_I:O=JFV&_A&RXB_P"!?^RM7SEK'ASXK_LW:?/8RVJ_%?X8,-DM
MG=H9;B"+TV_-M_\ 'E_W*^QH8NCBK*GI+^5NUO\ #+]'H=',<?>3?#?PWJUA
M*NO:O\?/%;(L>D:2S/+;VJ_P^:?F^;[OR_\ CE;OB_09I(=/\3?M ^*;?2=,
MM6^T:9X&T4_.?[B;5_[Y_P#9UK.\)_%2_P#$TSZ)\"/A;'X;U.\_X_M:NHE*
MP+_O?=7_ #\M>R_"W]C/2M+U(>)/B'J4OCSQ5*WFM)?,S6T3>R-]_P#X%Q_L
MUT5ZM/"ZUI-/Y.7RMI%>>X'!? FP\2_&[]HUOBU=:+-H?A>QMFM]/6Y7:TJ^
M6T2JG][[[,S?=Z5A:7_P3W\76/[<TOQQ;Q-HSZ$VN2ZK_9NR7[3L=&7;]W;N
MY]:^[K>VCM(5BA58XU7:JK]T58^]TKX_&8QXNHIVLHKE2\D<Y\J_MW?L8I^U
MUX1T.+3-0M-%\5:+=;K;4+N-F1K=QB6)MOS?W&'NO^U7DW[#_P#P3G\7_LL_
M&:7QGK7BC1]9LVTR>Q%O8K*K[G9/F^=?]BOT'HKC _,?]IK_ ();>.OCE\?/
M%7C[1_&.AZ5:ZM<K<0V]RDWFQ;41/X5_V:VOV8?^"<?Q.^!?QM\.>--<^(6G
MZ[IFEF5I;&&>ZWR[HG5?O_+]YJ_1ZB@#\S]<_P""8?CWXN?M#/\ $'XJ^--'
MUC2KS4!=ZAI^GI-O:!3\MK$6^ZNT*OTKW7]N#]B#3_VJO!^@Q^'[FS\.^*M!
M;[/9W4T1\IK/^*W<+_"/E9?3_@5?7=% 'S;^Q'\#?B%^SM\-YO!'C/Q+IGB;
M3+.7S-(FL?-\RVB;.^)M_&W=\RX_O-7SW^U]_P $W/&7[2/Q_O?'ND>*M$TJ
MPN(+6%;6^27S?W2;6^XM?HM10!0AL3#I*VFX;EA\K=_P'%?GU^Q__P $W?&?
M[-_[05IX^U?Q5HFJZ?#;W4+6MBDOF_O5VK]]?\XK]%** "OSH_;1_P"";GC'
M]I[XXW?CC1/%6BZ/9RV-O:K;WR2^;NB7'\*U^B]% 'Y'P_\ !(GXS131,WQ9
MTS:K+_RWO*]'_:8_X)I?$+]HSX^:EXWO?&>A6VD7#6]O!9.LS316L2*NS[N-
MWWV_X%7Z4T4 >1ZG^S#\+-0\,W>B_P#" ^&XH9[-[,3)I,'FJK)LW;]F[=_M
M5\A_L<_\$Z/B)^RS\<K+QE+XST'4=%:VGLKVSM4E66>)U^3;N7;NWHC=>U?H
MQ10!\?\ _!0+]COQ!^V!I/@NS\/ZYI^BG09[J6:34$=O,\U(@H7;_N?K7L7[
M*_PCU#X#_ 7PEX$U2]AU"_T:!XI+BUW^4VZ5W^7=_OUZ]10 4444 %%%% !2
M444 58[6&U1O)C6/)YVC%6J**)-M78"T444 %%%% !1110 4444 %%%% !11
910 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>nxpl-20230505.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaSCqbP9z5Z8GekhvWB4bfnKfywpuHgORiqMoDH2Qe8F -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:NXPL="http://nextplat.com/20230505" elementFormDefault="qualified" targetNamespace="http://nextplat.com/20230505">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://nextplat.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="nxpl-20230505_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="nxpl-20230505_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="nxpl-20230505_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
    <element id="NXPL_CommonStockParValue0.0001Member" name="CommonStockParValue0.0001Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NXPL_WarrantsMember" name="WarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>nxpl-20230505_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nextplat.com/role/Cover" xlink:href="nxpl-20230505.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nextplat.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="nxpl-20230505.xsd#NXPL_CommonStockParValue0.0001Member" xlink:label="loc_NXPLCommonStockParValue0.0001Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NXPLCommonStockParValue0.0001Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="nxpl-20230505.xsd#NXPL_WarrantsMember" xlink:label="loc_NXPLWarrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NXPLWarrantsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>nxpl-20230505_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="nxpl-20230505.xsd#NXPL_CommonStockParValue0.0001Member" xlink:label="NXPL_CommonStockParValue0.0001Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NXPL_CommonStockParValue0.0001Member" xlink:to="NXPL_CommonStockParValue0.0001Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NXPL_CommonStockParValue0.0001Member_lbl" xml:lang="en-US">Common Stock, par value $0.0001</link:label>
      <link:loc xlink:type="locator" xlink:href="nxpl-20230505.xsd#NXPL_WarrantsMember" xlink:label="NXPL_WarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NXPL_WarrantsMember" xlink:to="NXPL_WarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NXPL_WarrantsMember_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>nxpl-20230505_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nextplat.com/role/Cover" xlink:href="nxpl-20230505.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://nextplat.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="nxpl-20230505.xsd#NXPL_CommonStockParValue0.0001Member" xlink:label="loc_NXPLCommonStockParValue0.0001Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NXPLCommonStockParValue0.0001Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nxpl-20230505.xsd#NXPL_WarrantsMember" xlink:label="loc_NXPLWarrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NXPLWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140332698699456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 05, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  05,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40447<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NEXTPLAT
CORP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001058307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">65-0783722<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3250
Mary St.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Coconut
Grove<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(305)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">560-5355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NXPL_CommonStockParValue0.0001Member', window );">Common Stock, par value $0.0001</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NXPL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NXPL_WarrantsMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NXPLW<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NXPL_CommonStockParValue0.0001Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NXPL_CommonStockParValue0.0001Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NXPL_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NXPL_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:NXPL="http://nextplat.com/20230505"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="nxpl-20230505.xsd" xlink:type="simple"/>
    <context id="From2023-05-05to2023-05-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001058307</identifier>
        </entity>
        <period>
            <startDate>2023-05-05</startDate>
            <endDate>2023-05-05</endDate>
        </period>
    </context>
    <context id="From2023-05-052023-05-05_custom_CommonStockParValue0.0001Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001058307</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NXPL:CommonStockParValue0.0001Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-05</startDate>
            <endDate>2023-05-05</endDate>
        </period>
    </context>
    <context id="From2023-05-052023-05-05_custom_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001058307</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NXPL:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-05</startDate>
            <endDate>2023-05-05</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-05-05to2023-05-05">0001058307</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-05-05to2023-05-05">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-05-05to2023-05-05">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-05-05to2023-05-05">2023-05-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-05-05to2023-05-05">NEXTPLAT CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-05-05to2023-05-05">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-05-05to2023-05-05">001-40447</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-05-05to2023-05-05">65-0783722</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-05-05to2023-05-05">3250 Mary St.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-05-05to2023-05-05">Suite 410</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-05-05to2023-05-05">Coconut Grove</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-05-05to2023-05-05">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-05-05to2023-05-05">33133</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-05-05to2023-05-05">(305)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-05-05to2023-05-05">560-5355</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-05-05to2023-05-05">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-05-05to2023-05-05">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-05-05to2023-05-05">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-05-05to2023-05-05">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-05-05to2023-05-05">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="From2023-05-052023-05-05_custom_CommonStockParValue0.0001Member">Common     Stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-05-052023-05-05_custom_CommonStockParValue0.0001Member">NXPL</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-05-052023-05-05_custom_CommonStockParValue0.0001Member">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2023-05-052023-05-05_custom_WarrantsMember">Warrants</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-05-052023-05-05_custom_WarrantsMember">NXPLW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-05-052023-05-05_custom_CommonStockParValue0.0001Member">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>16
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M;RG;'2W3XOO%7&HMXV)SQ1FXKKD SB^DU&\[YI-(^45K^"]02P,$%     @
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M/[&\UDX:?^:+X3]>?P%02P$"% ,4    " #-,ZM6!T%-8H$   "Q    $
M            @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( ,TS
MJU;S9%9G[0   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E
M+GAM;%!+ 0(4 Q0    ( ,TSJU:97)PC$ 8  )PG   3              "
M <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ S3.K5NF\PRJ)
M!   W1(  !@              ("!# @  'AL+W=O<FMS:&5E=',O<VAE970Q
M+GAM;%!+ 0(4 Q0    ( ,TSJU;@]#J)J@(  # ,   -              "
M <L,  !X;"]S='EL97,N>&UL4$L! A0#%     @ S3.K5I>*NQS     $P(
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9>&UL4$L%!@     )  D /@(  !@4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nextplat.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k.htm">form8-k.htm</File>
    <File>ex10-1.htm</File>
    <File>ex10-2.htm</File>
    <File>ex10-3.htm</File>
    <File>ex10-4.htm</File>
    <File>ex10-5.htm</File>
    <File>ex99-1.htm</File>
    <File>ex99-2.htm</File>
    <File>nxpl-20230505.xsd</File>
    <File>nxpl-20230505_def.xml</File>
    <File>nxpl-20230505_lab.xml</File>
    <File>nxpl-20230505_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>21
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 26
   },
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "nxpl-20230505_def.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "nxpl-20230505_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nxpl-20230505_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "nxpl-20230505.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 65,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 2,
   "memberStandard": 0,
   "nsprefix": "NXPL",
   "nsuri": "http://nextplat.com/20230505",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2023-05-05to2023-05-05",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://nextplat.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2023-05-05to2023-05-05",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "NXPL_CommonStockParValue0.0001Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $0.0001"
       }
      }
     },
     "localname": "CommonStockParValue0.0001Member",
     "nsuri": "http://nextplat.com/20230505",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "NXPL_WarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants"
       }
      }
     },
     "localname": "WarrantsMember",
     "nsuri": "http://nextplat.com/20230505",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://nextplat.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>22
<FILENAME>0001493152-23-016251-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-23-016251-xbrl.zip
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MIS/4E;C(,A77,,!L&09^_\V/*G<(>ULE3UNX17[^\>3B9'(9#@=5,_T%%C<
MT<&5A=-E7LFJYTF*(@OBHVIHHJQO0*P"VCAV(^&C(*95$^74R"5*"HCHJU$T
M'AV.<=M@N\YNG,#;1K"A$C5+<Y#GJ<J*^W%(DOG7H@PNFDP%K_>_PI]>J.LF
MXXUS'"S*8MYDU[0A:Q3W!J:G9(F4?02-5BGL1NQ)6E6-HOY5*LOP$]I31F*=
M?68_@PE1=ZJ,LFQ)7^=%'?Q2I'F-HN\TKG=F,(-.N3T(X6UFJ#)XW3D8]+R
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MPY!\^R:+Z7^0 #6M-',8NBK=9 3$J#O)J7U)$*VV7+I;M/;%'4$[S70IM/-
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M._WA60V+LMBN6LPZ=&/H .,<\UB83J<J@JR@:L@!I2I(]AI=(HZC"/2$D(E
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MR\K\^!S79IG(VGPKLGT^W #<!2P_&,F G%-.MLPJ2S)SFP;)FD.B/??D(/
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M68PIID1*S!4[/M;W-(;* "QN_.VTR"!?.<W@0EGWJQ<\\#^_PTJD.(I*Y=@
MKOF'VEBS6$)%102EIJ35I IEY))[<5),Z>+V<K5]&PGT!V<H<4$6L,>\6W9^
M[NJVB+_31O:8N[75'LS97F9E/<.KTM;>>3(V-\"IX9%N!C@);:V,@,>&%L/]
MJS^OCHI%'14O\:@X+/(?.E"[@ @$"S?D7TKHA7F:8>X=Q/]FX<QV:*.WIG#U
MG!^5I*N+^N@$L<L-_]0%*&V2<XN_F]5])PBL#BW(T$FI(/CZ@]0T840'I=BE
M_IX%;P4/#MDSP@EG-<=T/ H; 2<H4FQS9,F/C%EZXP&DT"Y9)]5]P0Y\..35
ME_@[V<N(-&@7<JO0&I_G+D2&I\74>3R93DO: 4VB=FE:$7U.TVGK6U[,R(^'
MN#(ENX1&&:RG4)F;+ =(S(RO55VE=4#MS+L#&9U4O0PA;:M2,GX%0G3F>3O-
MXE<=E#)GZ9>'"&\.2G'DLHJH:&-^G).HFQL>$_BS'271/.?^KJ&XT)S-$YP.
M\.^IG@2"I\F,2+N;4<*F;%M';._N@=;0,/;6W#AR-3RVZY:-6$@;O"@APK$1
M0Y/8\IA!7$$R;,0(AYMFN"_'3S)G+LH4T/,-8GH&I_?6C&\>7-],/09NM7V'
M+X)X'99D;IYCS$FKSJCN]4HU1C9)X,7@&TNB'5,R=MEL; Z-M)A5 N*G*G;J
M1B@<Y)>2[A$^$;)5@(B'27D/^H0O?_C[ @ZHZ&[GD\<L<<,!]:A,D$=I5;U"
MJ^HCQ8N/RV)H[LK*,Z>\LE^S1,!?&UZD"5+[;[Z"ST9Q7<?PNXCN[] NF''X
M+#?/FO)['+D&H ="E+F.KP]P!%=%^9E8B:<9LV00KL"I2&)$NTHEWD_O>8U1
M3\$OM9A-/ (1S_6Q5U"2#NIH7>NN,@-",>*#TOP"#BXK3%; >1&7<$.9O=P,
MQ]L'6X>0N$C!")J6T+9ABMS*$-.4AI=I(E7IW&R?8*+T?]XW?N<E /K@M >T
MLAT 1_#'SU&EM)&Y :7F%.#-R0:B9B^S8FSKFM[O'>_"'X_>[^[I<.D3V._S
MHY;/MU91RX5&+9]OK:*6CV\3+7>77FP^VV((HCF/<R+.4!6?#K1!]^BI7]7H
MQ\6:)!I; 9VBC-]#,2N(DS:R\N3H@F>@['QG_"ML&UB[*7 GF7] ?C5/??P'
M.5$8'%C'?S<B#I4PI8X0.@L< L:D3>U-8TSE0IB\.$8!+[9LQ B<QXI/+R\;
M1WCFB0^/GXJ\@ ?^:J//':<G7UT4$FNM6FQ.ZZKH%4AN.;%H:V]W.GC#H=<6
MQ+D5*C;=<"4Y-P^WF1KVMUKCCC%L._)?--S1EXPV(*1O-]SV$SS*F)V=<LO6
M82K,4$AXW#D6QY"XMY5#9C0F&.(A-CP'SC$^7E$A1YCQ/+$ AWQJA\OI4^0?
M_EL@'PV4L\%G&)(.OZ_8]5>,8RY^;C;/OV=$30*>+];@5!8D[^P@F">PTVKU
M0"<"!N9M4>;I=<5F6S22O4(?![<<Y>4L68=XJ@V7"T<&R^FJF0!GL5*":IB(
MZP3M8*Q2 K.*5-<Q:P^,@R6A;4;*YW?X-!FU*ZIXR6B$)$!2J(AX15F41N9$
M2'UL>AYQ*9E&#74&W['>!;%95*TCSG9BJ3N\LQ&'0M#,$ 2-IS$@]QHQE0E'
M'+,2G' ;V- 1DP'5OBFFCH:MC><$EYD;R]U^MPV2H/D)@VN$T/ N06(U0NN"
M,T:UOJ%4-!G[#LI'B*04L7"Q"YFZR0XU4UP(&)C.^:= AZR 6^10/ R<RZK(
MV=$\9]V*[JUA7,W&D0D9K2>%'FX=B2K )7DL,GH(*<'2GR VQ385@OA #AA@
MXJ1G46@>"#DS.CQ%# +P/2GAWBB8[.)#YJ2*9TD_.B_-^01E .9 0JNS(/*R
MT6P<3;**W[VQ"<$8'-7XLL@2 3$FQ6Q0-ZH>\3HOTVPR0)^P@:VC%F.I*G[,
MGC]RMFD^1O5G>QK9SV%,$P/["/8Q30!U1UV6%0#WJ",,P%&D_T?_A&@47J"
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M!7,]XKD(C8&AQF@MTB]1;78IE2@"Y.EC[%++\%@8.#O8?0T0[; .V(99W]W
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M)M,4U,Y\)PG<?40QXU8P5N(8XQC]Z++(T$.8Y6QS@BW6YP0$D 0R! ,#%<
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M2,$#R2"ZB<*7,,I].?58#06@>-5Y@?10@VMJ1>E[1^@LC:#/"7P;G1'A0T&
MO#7<6WYE9"R%JD[IK2G5[I8MV+UXWSF>T-JE(/ZK$,'=(,X_E[-I/>13G5!U
MYN$"JL/?#LF'@Z>*="<:(&02P@ /R6HC[[OV%I\ZE= )MUZ5CWJ)F/+33IID
MTG"ZN":"AI%,-$!**3?T$@O5&;<%A=)T @?S%RC@(ID^6747<>(H5B<@NR*N
M86.MF450C$;V\ZQ6FCR!,_.&(/?+59![L4'NET\WR/T(+_]'<2[LB+S&@7G#
M-,77F(5+#!2:1$,0@D?*-H83&$/@JHBO@7MLE,>Z*RUL=>#-3F*!UFY&J4 E
M%-AF;VA0+XB&78<(VA3P0:1<;E&G@B!7YC=>^HBD;-+4WJ8--_1T#DBV*#V@
M*W)*M;YON\B_)RQ4DSO=F7K"D572=0R4GP$PKL+_-MT\E,66VH.+;(H2UQ)^
M(/.#)PI@2<)?8L?E,T;J1^067J,"B44* 7)PQO(DUK+5[R[U5)EV#*4>@*I
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MS</%89$FL%FH.B?=H+J$T5YV@Y,BC$"6P4;,6:/O)/A7^$(VFPSY>><9T.E
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MYU?#":*G[CS/<MS'CE-AQ0M@^(YJ$:UQ1%=WL9O23*N9<I!6<:?S61I96KS
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M125+,BVL&@TN^Z;AN=R7GGMSD2M^4CTC*HZ)\M>BG0C&0."_%*0F>0D$(J4
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MB(KH4?XCQ;P9=A3JEGX8$<$G<!IG@EF8*^2#%<6A!P1A83UHP?BFW(/2T:J
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M[8TO^ ._EBM(K5[JIEI))O1]&$R/8^)7)N0_ #JX$Z[Y*(_LEJ>\WI3F37F
M3'@U!0GNN/3)]2=V>)YG<F\UE/;;EGIC.?SP-F4P"9.4OV]TH.]\5^XD"AB]
MX?EYFP&_]P*U+X]!%ZU;/'*4Z&AXF$=IF]"KW JORYV&V+RYQA6XK:.^K;4N
M//;OXP9[1ZU8YST>]%T=[BT7 GI"94UN>RDWZ'Z^]?)M<#"EIB%O@D]A6:WQ
M#0\ZBG]'9/]B^V#W=[S*+SZ>?/[T_O\#4$L#!!0    ( ,TSJU9W;28_DPD
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MF$<7<*-<<D04BH@JU #&99EA+X0?TF"9'13Z!BYAU)F3N?!<%A&./N(S#GJ
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M1H\*T>^W[/N"N:)1OR5^#;E4DN" L+T8H&+]]Y5F3JO:@N%;C-C# ^:Y&'R
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M$B#E&:FA*LY/U E-CT*E7QYJ^F$3:EIIJ.F'QQAJ>MP].48UFY,3OX)CM*M
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M16*LI(79L.Z:,?&UL=9??.=%TTDB3PZD_MIE8!675$7S= ]*,R,TM[#>F*I
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M!U*PIVONM!+_!B;PR$9._:4H$1U4:LP4=<[@EM18K@6(<P%"2=>:TZ6/_72
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M    97@Q,"TU+FAT;>U<;7/:N!;^S@S_03=S;R?I$/+2IC.;T,P0<!IF4F#
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M &15&W5L^3/&$NFQ\L=B3+WVS9%>&:)*>\J_-!*!+/\Y/"37G 7^.1G2&;L
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MD0]04V3OYSW&S[T[*)6K/W[4?K_I7F_+#3W2RY?CS#>4O;@%ZYF6Z.7+3?2
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MGBS2B@RI 1X]^@3B>9BN0:AX/?4K+$;!"L\9['W&/D-1DD1VA,+PF>A*E"_
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M9'N[(;JO#%IQ#518803;,$@1+M:<1<#J;4,Q#4?+8K9I\Q3RSCH%>ST#"W'
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M'RS;7']*F2J@J@^!-\!44!P^9?EE&D?H2-'JMF\S3 2+<Z7.3"%\M$D,R'+
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M7@3OPK+:()WN=:&=]:\S_U47\F3G<.\7O-U/WIZ^?_?Z_P-02P,$%     @
MS3.K5L>C/DH9"P  IS$   H   !E>#DY+3(N:'1M[5MI;QLY$OTN0/^!:TP"
M!VC)1R:;]1%C;?D8+^1C+&4R^;2@NBDUXVZR0[(E*[]^7[$/'9:3[*YG,@X2
M(+;Z(%D77[TJRON_]"^Z!\W&_B\GA\?XS>C??O^\WSTYV-\H?N/I1OEX_^CJ
M^#WK]=]W3]ZL#;5RNVQK,W.L+U-AV:68L!N=<A44-P+6$T8.US 00Z__VW%[
M+.5F)%7+Z6R7X?7ZQD [I]/RGA-WKL43.5*[+!3*";-VL']Z==F?7Z\UY*E,
MIKM?6M&_:^4G40BX=O!<#6RVM[]!$\(BU_^G+E[FV?]%Z8T<Q>XQA=\_.CBY
MB^5 NF9C9Z>]O;]Q=/!HJGQ3MT"SRC/?6*7SBS/6N^F\61-W.SNM[7]O;FZU
M/V2C-7;8[;]96_MAZ+^B2I=8X#KAV!8]9X0:N5@HBW&8QVEV;?3("&OE6+ .
M-X*=J["-'V-AG50CQA7C422=U(HG[*<M=B&3!!=[>!*QD[LLT89FB@6[UIAF
MD C6RZ32PR'30R:=96>)'O"DV>B+1%CN_, K@XV*"7O<A3IE1[F5"E*PMPHC
MOB/SG]<1=?YX*GT66#_D<-QP^LA!U+GJ7%V^[3<;9S=7OYT$[+3+GJN(VWB/
M7? IV]I:6&W P]N1T;F*6J%&@.RR22R=6#L(V/;F]DM66^+HX.O&56O-8KFC
M3<;6]]\>7![VC@]_W667OU]W __SW?[&VX,7;/UY$GW,]5XUYKGQETP;'ZWE
MTXY.,ZZFY<,7 >-LY..5"<B0IL*$@F5&CV4D,%!'T)8K!1E#$34;+D9 2\=B
M;AE>SQ+A1'1_TZ3%IF'2[ZL4<8:/#^R]]:M^Y]>C77;S^\6QER<3QM)$\$C$
M8L$3%X?TMA5F+$-AFPW:44Z$L8+11E,O"'2J+;"\3J5LN_;#$PW,/Y.P/+KX
M>^S!<#]7S4:HE1(AA1";2!?[F%T924&]*UB6FQ"1B##Y^=6K8'-SDRDQ2:9,
M6IOCI@=70N7E@ B*)00/8_^2CR C+44X7M<*P193R*T8^]Q8"B;+L)-2"-9S
M.KSU&$_#WG%C.*(=F:82#A%=3[8XQA7!7HA0O=YL0)+0O_W3=GM[DY)3O;OF
M="= "&ID>;00NX"JQK815E\%5*?"*.@N/GD+'$%[X73@+T)A',>NU_"D8;%.
M "C>&_#T&,]\ZE3:B<I=@^D]8V.KXQK/8,]RF \,G@&B[F3*G8"[8:>=.E#(
M?[FS#B)0/H<Q52@SP!+)Q,/0Y!ZP(I:KC,L(@84<B-#"M4>\N!0**WJWD<C-
MQE=& 7FTD-.2+(N>]+[V<[;9,9\ X]B_.'FG)\+<P+_XZ!&1@(Y"$1CKD74L
M+4!\Z(%<@GL@PBSW6Z5=!< AF(X[U7>L%\825*3;O0X0C#:&#1S%S7$'7@D]
M6!-RY\J*A'0D?<N<0!"]8A<"]&<+%J[MYJ&VMU-V9+2^]5%% ?9>FUM\>A^4
M"BRMM&S"]A/%L>\7AOM+SF;#W/C-:W4B(SF4?IF*790;(-/60Q-YVP>_,QH[
M$5O/AWJQ[U<!:9N=XD4]H5<I"L,$,^$S7KT?=37LZ0G(_#TB4>Y"BLUK(X8"
M,!25>]*(#*]B=WAVOX ;+__1_OG99S'>:4=,?AY0QMK/9.L]VV;]N3TD[C+L
M'U]JB#N0*4D)0$4;V+P5@-D<:2?3QI5P14EJ'A-)BW(LQ_5]\)E;G-8!P!E!
MB88F$A]SZ:8>;B&F74F[,";5]#L&O+S:?%8)4>*PSV4SC9N-KU69N.&#ILP0
M#2D/I\$J2L>6&-V@K(_P9 )<;S8&9!8F4S(;Y5=*V,BW^%2$"ZMY;;D<!:)4
MI(X8ZR2?1>@*MHNX KBF/P#IKP9(/9%QX_=J0*7'+.2H_$!IST?P[P.I-"AR
M*6+=)U#QI4Q7[D)+=0^GVYX*<L*WHLJWJZI\5A7YA$"YDJ$?:EG71:OJ?E_%
M5<$-QD$3<;L@6A6X*'/\?OY2]*ZNA7[$\K?K'1P.@)[-Q@)3?]06SS?0Z0_H
M$_[96LQZ*?+S>:#N)U!:=67QP3/:QY@.91Y+\\3)#)@0RU'< G1- "!(CTZ;
M(I5!PUN!W4N</8NG%KA0%""1''D\X,AMCLJL_@(J.:$B6Q0[2<('FL"O@*=9
M1@R8SIQ,Y:>2.$G#^$ FE/6I9A%)4MX=:8W)M (90\4;Z91:G! $:.IE\96/
MXD77QD.L9QX*I(.F#N$"C"DU A [11=8HUQ?E.LL-(Z(:I6H9,18 ,C:,_(&
M;*8Z!=1+9X2R/O'/CP\74+39J/E!)('AA((N1J(8Q8\+P9ZY -M!5,<:Z\%:
MW/& *JWP%K8H37.N^S/&0DZJ+331)HDF2!VU?'6(E'&&-T%,#8+2/EUL_CZ
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MSN!C[)--9:64/)D*Q70-QQI'\]=[&!H*\(TD(M2H=MNXFK0RV,@9ZM1)*^8
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M68UJHQ*/^1OG*5VP7R/XC/B/2)\^($BG#W.9PF+-L-"L09)C\ @,(QU&M,&
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M!]K,Z%$L:EZFCS;X/!\IXCZ-$HDT7[YG4K'61"B4H?$=D^'5)>"GAUXHU-;
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MQD TM!9IL2<B_KW!/",\>>Z$HJ%TS05@U43#D 5%A]T;"$@I]\O('<<TC>4
MU@E)4^K\= ,PVSCU,'1!<0*8@T])2KU?4J;W)$GDW0N8=@\H-K%K6F##)B]-
M95#$@/9 9E0$RD/"P>;L4:[.Q3*I9V,K>I_P-&RW\5.*@T7(=-B3(A6&9)PG
MDBHW370PU%"ZI@>P:G)CR((BQNX-9$7+D=+[A^2,SGLA4NK\ &+8M..1BP*$
MH^ZL"PVA]@G&>9Q&.-%>SL4V\^>5#JUK0$"[)B0-85"@0.Y 6'1 P8P*\0K,
M?PCF_7"I*/W TK!J1Z64!0B*Z:T+$ZGW LGIAO.::WC&@:6N,.DR6W "Z8(
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M,"TQ+FAT;5!+ 0(4 Q0    ( ,TSJU9D0<H"O3X  -R2 0 *
M  "  8RR  !E>#$P+3(N:'1M4$L! A0#%     @ S3.K5G=M)C^3"0  8D@
M  H              ( !<?$  &5X,3 M,RYH=&U02P$"% ,4    " #-,ZM6
M3/[T9D@]   !A $ "@              @ $L^P  97@Q,"TT+FAT;5!+ 0(4
M Q0    ( ,TSJU;A_9GA6@H  /!6   *              "  9PX 0!E>#$P
M+34N:'1M4$L! A0#%     @ S3.K5K)6'J^F/0  EI<!  H
M ( !'D,! &5X.3DM,2YH=&U02P$"% ,4    " #-,ZM6QZ,^2AD+  "G,0
M"@              @ 'L@ $ 97@Y.2TR+FAT;5!+ 0(4 Q0    ( ,TSJU8T
M<LA[JQL  )_J   +              "  2V, 0!F;W)M."UK+FAT;5!+ 0(4
M Q0    ( ,TSJU:$FV8=X0,  %H/   1              "  0&H 0!N>'!L
M+3(P,C,P-3 U+GAS9%!+ 0(4 Q0    ( ,TSJU:7>HF'Z @  !AH   5
M          "  1&L 0!N>'!L+3(P,C,P-3 U7V1E9BYX;6Q02P$"% ,4
M" #-,ZM6RGG*(\L+   NCP  %0              @ $LM0$ ;GAP;"TR,#(S
M,#4P-5]L86(N>&UL4$L! A0#%     @ S3.K5H%C[-DN"   LF(  !4
M         ( !*L$! &YX<&PM,C R,S U,#5?<')E+GAM;%!+!08     #  ,
+ ,D"  "+R0$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
